- AstraZeneca to acquire CinCor Pharma in a deal worth $1,8 bn 11 January 2023
- Eli Lilly to buy gene therapy company Akouos for $487 million 27 October 2022
- Hetero acquires Johnson & Johnson's Telangana plant 26 October 2022
- Torrent Pharma to acquire Curatio Health for Rs2,000 cr 03 October 2022
- Moderna sues Pfizer-BioNtech for patent violation 02 September 2022
- Sun Pharma chairman Israel Makov to retire on 29 August 08 August 2022
- I-T seizes over Rs142 cr in raids on Pharma group in Hyderabad 11 October 2021
- SaNOtize's nasal spray eliminates 99% of Covid-19 virus 22 April 2021
- AstraZeneca to acquire Alexion in a $39 bn cash-and-stock deal 23 December 2020
- UK authorises emergency use of Pfizer-BioNTech Covid-19 vaccine 08 December 2020
- Covid vaccine faces rejection even before it reaches market 30 November 2020
- Huge response to PLI Scheme for bulk drugs, medical devices 30 November 2020
- Cease-fire on the Vaccine Front! 04 November 2020
- Bharat Biotech gets nod for Phase-III trials of Covaxin 26 October 2020
- Govt targets 10,500 Janaushadhi Kendras by end-March 2025 19 September 2020
- Ensure Covid-19 vaccine trials follow `scientific process': MNCs 10 September 2020
- Tata Motors, Hyundai win EESL order for 250 electric vehicles 04 September 2020
- Kodak to turn drug maker with $765 m US govt loan 30 July 2020
- Dr Reddy's to acquire select businesses of Wockhardt for Rs1.850 cr 13 February 2020
- Sun Pharma swings to Q2 net profit of Rs1,062 cr 07 November 2019
- Sun Pharma licenses AstraZeneca to sell its oncology drugs in China 06 November 2019
- Drug regulator sounds health alert on antacid ranitidine 25 September 2019
- Roche's $4.3 billion takeover offer for Spark extended till 1 October 05 September 2019
- CCI approves GSK-Pfizer consumer healthcare JV 24 May 2019
- And now, formaldehyde found in J&J's baby shampoo 01 April 2019
- Sun Pharma's Q3 net profit vaults 49% to Rs1,242 crore 13 February 2019
- NITI Aayog delegated NPPA role of drug price regulation 24 January 2019
- Pfizer to shutter two more plants in India 09 January 2019
- Eli Lilly to acquire Loxo Oncology for $8 bn in cash 09 January 2019
- Bristol-Myers to acquire Celgene in $74-bn cash-and-stock deal 03 January 2019
- J&J told to stop using its baby powder raw material in India 21 December 2018
- Indian drug regulator may revive probe to J&J's baby powder: Reuters 18 December 2018
- Medical stores protest plans to regularise e-pharmacies 28 September 2018
- Health ministry bans 328 fixed dose combination drugs 12 September 2018
- Aurobindo to buy Sandoz's dermatology business in US for $1 bn 07 September 2018
- Fake, low-quality medicines flood developing countries 13 August 2018
- New compounds to treat RSV, Zika virus identified 12 July 2018
- Stop antibiotics before resistance 'tipping point' 11 July 2018
- A new kind of vaccine based on spider silk developed 15 June 2018
- Sun Pharma gets US FDA clearance for its Halol plant 13 June 2018
- Eli Lilly to buy Armo BioSciences for $1.6 bn 11 May 2018
- New uses for existing antiviral drugs 25 April 2018
- New York doctors charged in cash for prescription scheme 17 March 2018
- Delhi HC attaches Ranbaxy promoters' assets to enforce Daiichi award 26 February 2018
- Daiichi case: thwarted in SC, Singhs may return to Singapore courts 17 February 2018
- LyondellBasell to acquire A Schulman in $2.25 billion deal 16 February 2018
- NPPA lowers ceiling on stent prices further 13 February 2018
- Ranbaxy's Singh bros must pay Daiichi Rs3,500 cr, rules HC 01 February 2018
- Sanofi to buy Belgian biotech company Ablynx for $4.8 bn 29 January 2018
- Celgene Corp in talks to buy Juno Therapeutics 17 January 2018
- Celgene to Acquire Impact Biomedicines for upto $7 bn 08 January 2018
- Luxturna gene therapy to cure rare blindness 05 January 2018
- Bharat Biotech scores big with WHO-approved typhoid vaccine 04 January 2018
- Price of cancer drug Lomustine hiked 1400 per cent since 2013 29 December 2017
- Martin Shkreli's former company lawyer convicted for fraud 28 December 2017
- Opioid crisis hits US life expectancy 23 December 2017
- N Carolina sues pharma company over opioid marketing campaign 22 December 2017
- Roche to acquire US biotech firm Ignyta for $1.7 billion 22 December 2017
- Indian firm gets regulator's nod to start Zika vaccine trials 19 December 2017
- Drugmaker Sanofi under fire over Dengvaxia reverse 18 December 2017
- US pharma industry challenges California's transparency legislation 09 December 2017
- Stryker Corp to buy Entellus Medical for $662 mn 08 December 2017
- Gilead Sciences to buy Cell Design Labs for up to $567 mn 08 December 2017
- Nestle to buy Canadian vitamin maker Atrium for $2.3 bn 07 December 2017
- Over 10% of medical products spurious; poor nations worst hit: WHO 06 December 2017
- WHO to review Sanofi's dengue vaccine Dengvaxia over safety concerns 05 December 2017
- IMA releases draft norms to curb rampant antibiotics misuse 04 December 2017
- India scores well in WHO's latest estimates of spurious drug problem 29 November 2017
- The future of sutures and staples: A sealant inspired by slugs 24 November 2017
- Glaxo arm gets US nod for first 2-drug HIV treatment regimen 22 November 2017
- US drug distributor AmerisourceBergen to buy H D Smith for $815 mn 21 November 2017
- Koch brothers support Meredith bid for Time 16 November 2017
- Suven patents neurological molecules in India, HK and US 16 November 2017
- Kentucky accuses Endo of contributing to opioid epidemic 08 November 2017
- Study finds strong evidence that stents are being used needlessly 04 November 2017
- Torrent to acquire Unichem's business in India for Rs3,600 crore 04 November 2017
- Major US lawsuit accuses generic drug makers of price-fixing 02 November 2017
- CCI imposes penalty on pharma dealers body in Kerala 02 November 2017
- Novartis buys out cancer specialist AAA in $3.9 bn deal 01 November 2017
- Amazon eyeing pharmacy business: reports 30 October 2017
- Walgreens to shutter 600 Rite Aid stores in mega deal 26 October 2017
- Amazon likely on verge of entering retail drugs business 07 October 2017
- FDA warns against Intercept's liver disease drug after 19 deaths 22 September 2017
- Pfizer, J&J in legal battle that could shape biosimilars market 21 September 2017
- Fresh hope for heavy drinkers: new drug may cut craving 18 September 2017
- Allergan transfers drug patent to Mohawk tribe to sidestep lawsuits 09 September 2017
- US drugmaker allegedly pushed opioid sales using dodgy tactics 08 September 2017
- Poultry waste raising antibiotics resistance 02 September 2017
- Gilead Sciences acquires Kite Pharma for $11.9-bn in cash 29 August 2017
- Dr Reddy's plummets on US lawsuit over 'corporate quality' 28 August 2017
- Pfizer secures Indian patent for its pneumonia vaccine 23 August 2017
- Novartis begins human testing of new anti-malaria drug 21 August 2017
- Draft pharma policy seeks to bridle NPPA's pricing powers 18 August 2017
- Govt slashes ceiling prices of knee implants by up to 69% 17 August 2017
- Alternative medicine for cancer raises death risk: study 17 August 2017
- Govt looks to reduce pharma industry's bulk drug imports 04 August 2017
- Govt to block $1.3bn sale of Gland Pharma to China's Fosun 01 August 2017
- AstraZeneca and Merck in $8.5-billion oncology deal 27 July 2017
- Internet Brands to acquire WebMD for $2.8 bn 25 July 2017
- PPI drugs might increase death risk: study 04 July 2017
- Lupin founder-chairman Desh Bandhu Gupta dies at 79 27 June 2017
- Merck KGaA mulls splitting into three companies 17 May 2017
- US FDA approves Stivarga for liver cancer treatment 28 April 2017
- WHO to test first malaria vaccine in Africa next year 26 April 2017
- Aspen Pharma in midst of cancer drug price-gouging row 17 April 2017
- Fresenius in talks to buy US generic drugmaker Akorn 08 April 2017
- Democrats oppose Scott Gottlieb's nomination as FDA head 05 April 2017
- Astellas Pharma to buy Belgium's Ogeda for upto $853 mn 03 April 2017
- FDA approves Dupixent to treat severe eczema 29 March 2017
- EU agency suspends 300 medicines tested by Indian CRO 25 March 2017
- Scientists unveil a giant leap for anti-aging 24 March 2017
- After stents, Maharashtra cracks down on other devices 21 March 2017
- NPPA slashes cancer drug prices by up to 86% 07 March 2017
- India beware: WHO publishes list of drug-resistant bugs 02 March 2017
- WHO publishes first list of drug-resistant killer bugs 28 February 2017
- Lupin gets US FDA nod for marketing generic Percocet tablets 28 February 2017
- AstraZeneca licenses cancer drug Zoladex to TerSera Therapeutics 21 February 2017
- Price cap: latest stents disappear from hospitals, stockists 17 February 2017
- Authorities crack down on stent 'hoarders' after price caps 17 February 2017
- Merck calls off late-stage trial of Alzheimer's drug verubecestat 15 February 2017
- India slashes stent prices by up to 85%; cap at Rs30,000 14 February 2017
- Sanofi nears deal to sell some OTC products to Ipsen SA 13 February 2017
- Reckitt Benckiser to acquire Mead Johnson for $16.6 bn in cash 10 February 2017
- Regeneron and Sanofi need not pull Praluent off market 09 February 2017
- Spread of drug-resistant malaria bug should worry India: expert 04 February 2017
- Pfizer explores sale of some treatment drugs worth over $2 bn 03 February 2017
- Trump tells drug makers to get prices down 01 February 2017
- Mezzion Pharma sues Dr Reddy's in US for 'millions of dollars' 27 January 2017
- Trump's 'America First' policy to maul Indian IT, pharma sectors 23 January 2017
- Pharma industry seeks GST relaxations in the name of the poor 21 January 2017
- AYUSH ministry ropes in ASCI to monitor misleading ads 21 January 2017
- Superbugs may be spreading faster than thought: study 20 January 2017
- Mallinckrodt to pay $100 mn to settle 'price-gouging' charges 20 January 2017
- Unused prescription drugs regularly sold on eBay: BBC Report 18 January 2017
- Govt dilutes NPPA's inflation-linked drug pricing rule 17 January 2017
- Japan's Takeda to buy US cancer drug maker Ariad for $5.20 bn 10 January 2017
- Aurobindo Pharma acquires Portuguese firm for Rs970 crore 09 January 2017
- New US FDA drug approvals down to six-year low in 2016 03 January 2017
- Johnson & Johnson in talks to buy commercial portfolio of Actelion 30 December 2016
- Johnson & Johnson resumes merger talks with Actelion Pharmaceuticals 26 December 2016
- Antibiotic sales for farm use increased 1 per cent in 2015 23 December 2016
- Teva Pharmaceutical to pay $519 mn to settle US bribery charges 23 December 2016
- US Senate for curbs on "price gouging" of life saving drugs 22 December 2016
- Actelion in exclusive negotiations with J&J after talks with Sanofi 22 December 2016
- Sun Pharma acquires Novartis' oncology brand Odomzo 22 December 2016
- Sun asks US FDA to withdraw nod for 28 Ranbaxy ANDAs 20 December 2016
- After Pfizer, Actavis accused of hiking drug price by 12,000% 17 December 2016
- Teva Pharmaceuticals and Mylan accused of brazen price fixing 16 December 2016
- Novartis to buy privately-held British biotech company Ziarco Group 16 December 2016
- Merck wins $2.54 bn in royalties in patent lawsuit 16 December 2016
- J&J being sued over Risperidal causing breasts in men 16 December 2016
- Lonza to buy US capsule products manufacturer Capsugel for $5.5 bn 16 December 2016
- Actelion says J&J backs off, in talks with another suitor 14 December 2016
- Bayer, Versant Ventures to form JV for stem cell therapy technology 13 December 2016
- AstraZeneca to cut 700 positions 09 December 2016
- EpiPen maker Mylan to cut and restructure workforce 08 December 2016
- Pfizer fined for 2,600% price hike 08 December 2016
- Abbott seeks to terminate $5.8-bn acquisition of Alere 08 December 2016
- Sanofi mulls counter bid for Swiss biotech company Actelion 06 December 2016
- Johnson & Johnson ordered to pay $1.04 bn over faulty hip implants 02 December 2016
- Delhi high court dumps govt order banning 344 FDC drugs 01 December 2016
- Existing intestinal disorder drug holds hope for HIV 01 December 2016
- WHO finally gives nod for HIV self-testing; India takes note 01 December 2016
- Chennai's SIMS Hospital showcases robot surgeon 30 November 2016
- Gilead starts marketing Truvada as preventative against HIV 30 November 2016
- Theranos and CEO Elizabeth Holmes being sued by investors 29 November 2016
- Aurobindo Pharma to buy some commercial products from Teva 26 November 2016
- Johnson & Johnson in talks to buy Swiss biotechnology firm Actelion 25 November 2016
- Ficci formulates 'self-regulation code of conduct' for e-pharmacies 22 November 2016
- Novartis to buy Selexys Pharmaceuticals for up to $665 mn 21 November 2016
- Pfizer offers discounted Prevnar 13 for humanitarian programmes 12 November 2016
- Sun Pharma Q2 net surges 117% to Rs2,235 cr 10 November 2016
- Govt's Amrut Scheme to make 2,000 medicines cheaper by up to 90% 07 November 2016
- Dr Reddy's, Sun Pharma under cartelisation probe in US 05 November 2016
- US regulator targets generic drugmakers for price fixing 04 November 2016
- Female viagara maker Palatin Technologies explores sale 03 November 2016
- DRI seizes 23.5 tonnes of Mandrax tablets worth Rs3,000 cr 02 November 2016
- Mylan's price hike on EpiPens adds millions to DoD spending 31 October 2016
- NPPA struggles to get pricing data from medical devices firms 19 October 2016
- BSN Medical sale may fetch EQT Partners around $3.4 bn 15 October 2016
- Battery defect in St Jude's heart defibrillators causes 2 deaths 13 October 2016
- NPPA caps prices of 31 essential drugs 10 October 2016
- From Edison to miniLab, but scepticism still surrounds Theranos 10 October 2016
- Mylan to pay $465 mn to settle DoJ probe over EpiPen costs 08 October 2016
- Theranos to close labs, wellness centers, focus on 'minilab' 06 October 2016
- Intas to buy Teva's UK, Ireland generics business for Rs5,083 cr 06 October 2016
- Japanese biologist Yoshinori Ohsumi wins 2016 Nobel for Medicine 03 October 2016
- Ibuprofen could raise heart failure risk 20 per cent : Study 30 September 2016
- EpiPens in UK sold for 10% of US prices 30 September 2016
- US lawmakers seek to block DEA move to make kratom illegal 30 September 2016
- Medtronic Plc wins US FDA approval for artificial pancreas 29 September 2016
- Govt allays fears of rise in prices of essential drugs 27 September 2016
- Pressure mounts on India to curb antibiotics misuse 27 September 2016
- Mylan profits 60% higher than disclosed to US Congress 27 September 2016
- FDA approves Amgen's Amnjevita alternative version of AbbVie's Humira 26 September 2016
- Piramal Enterprises looks to buy OTC business of Morepen Laboratories 23 September 2016
- US orphan-drug developer Vanda Pharmaceuticals explores sale 23 September 2016
- Allergan to buy Tobira Therapeutics for $1.7 bn 20 September 2016
- US drugmaker Depomed explores sale 16 September 2016
- Make drugs affordable, delink prices from R&D costs: UN panel 16 September 2016
- Allergan to buy Vitae Pharmaceuticals for $639 mn 15 September 2016
- Horizon Pharma to buy Raptor Pharmaceutical for $800 mn 13 September 2016
- Bayer explores sale of dermatology business worth over $1.12 bn 09 September 2016
- Trial drug found promising in Alzheimer treatment 03 September 2016
- Dengue vaccine could cause severe illness: Study 03 September 2016
- Teva patent on multiple sclerosis drug invalidated 02 September 2016
- US FDA approves Novartis's biosimilar copy of Amgen's Enbrel 01 September 2016
- Nestle Health Science to buy British medical device company Phagenesis 01 September 2016
- UN health officials warn of gonorrhea becoming untreatable 31 August 2016
- Another setback for Theranos as it does rethink on Zika test 31 August 2016
- Mylan to offer generic EpiPen at half list price 30 August 2016
- Aurobindo, Intas in race for Teva's Irish generics business 29 August 2016
- Alere sues Abbott for completion of $5.8-bn merger 29 August 2016
- Mylan to further enhance access to EpiPen Auto-Injector 26 August 2016
- Mylan wins patent battle over sclerosis drug Copaxone 26 August 2016
- Pfizer to acquire part of AstraZeneca's antibiotics business 24 August 2016
- Card costing 1 dollar can test for substandard drugs 24 August 2016
- Zika virus could be around for two more years in US: expert 23 August 2016
- Mylan raises prices of allergy medication EpiPens 500% 23 August 2016
- New cholesterol drug not worth the high price, finds study 19 August 2016
- J&J loses rheumatic drug patent battle; boost for Pfizer 18 August 2016
- Lupin India's most reputed drug brand; Sun, Cipla follow 18 August 2016
- Lonza to buy InterHealth Nutraceuticals 16 August 2016
- Piramal Enterprises to acquire Ash Stevens 16 August 2016
- Novartis' S Korea executives charged with bribing doctors 13 August 2016
- DEA to make it easier for researchers to obtain marijuana 12 August 2016
- Merck & Co and Allergan eye US biotechnology company Biogen 03 August 2016
- Lupin to buy 21 brands from Japan's Shionogi for $150 mn 02 August 2016
- PE firm Advent in talks to buy inVentiv for nearly $4 bn 01 August 2016
- US diagnostics firm Laboratory Corp to buy Sequenom 28 July 2016
- Olympus sued as faulty scope causes 35 US deaths 26 July 2016
- Apple, GlaxoSmithKline in diagnostic platform pact 19 July 2016
- GE Healthcare to buy Switzerland-based Biosafe Group 14 July 2016
- Theranos penalised, Holmes banned from owning labs 08 July 2016
- Gilead wins FDA nod for hepatitis C 'silver bullet' 29 June 2016
- Horizon Pharma seeks stake sale to investor 28 June 2016
- MSF helps bring promising new TB treatments to India 10 June 2016
- Act now to prevent AIDS rebound, warns UN chief 10 June 2016
- NHS England to not fund drug that helps prevent HIV 02 June 2016
- Sun Pharma gets US subpoena over drugs pricing 30 May 2016
- Valeant mulls asset sales to reduce $30-bn debt 19 May 2016
- Pfizer to buy Anacor Pharmaceuticals for $5.2 bn 16 May 2016
- Sanofi prepares to replace Medivation's board 14 May 2016
- Bayer explores potential bid for Monsanto Co 13 May 2016
- Sanofi tables $9.3-bn bid for US biotech firm Medivation 28 April 2016
- Novartis to sell stake in Roche worth $13.8 bn 25 April 2016
- PDF drugs like Benadryl linked to dementia 19 April 2016
- Advent, Baxter in race to acquire Gland Pharma 15 April 2016
- China to punish 357 officials over illegal vaccines sale 14 April 2016
- US prescription drugs spending to hit $400 bn in 2020 14 April 2016
- Theranos may lose licence; top execs face ban 14 April 2016
- Global Fund stops sourcing IPCA's anti-malaria drug 08 April 2016
- Pfizer calls halt to $160bn merger with Allergan: report 06 April 2016
- New Treasury rules threaten Allergan-Pfizer merger 05 April 2016
- NPPA brings down prices of 103 drug formulations 02 April 2016
- US capsule manufacturer Capsugel explores sale or IPO 26 March 2016
- US FDA approves Bayer's haemophilia therapy Kovaltry 18 March 2016
- More drug bans coming: 1,200 FDCs under scanner 18 March 2016
- US warns drugmaker Emcure for 'fudging' test results 17 March 2016
- P&G follows Pfizer, Abbot, ends sale of cold remedy 15 March 2016
- Valeant Pharmaceuticals cuts revenue forecast by 12% 15 March 2016
- India bans Pfizer, Abbot cough syrups; shares tank 14 March 2016
- Drug firms ripping off patients with fixed doses? 04 March 2016
- US FDA has barred 11,664 Indian products since Jan 2011 03 March 2016
- Allergen deal to help Pfizer save $35 bn in annual taxes: report 26 February 2016
- Medicine packs to carry thin red line to curb misuse 24 February 2016
- US FDA approves Glenmark's oral contraceptives 24 February 2016
- Suven Life secures two product patents in Australia and Canada 19 February 2016
- Biocon gets EU nod for generic cholesterol drug 16 February 2016
- Intercept Pharmaceuticals explores sale 15 February 2016
- Scientists create mini-brains to test new drugs 13 February 2016
- Animal testing: being cruel to be kind, or just being cruel? 13 February 2016
- Drugmaker Mylan to buy Sweden's Meda for $7.2 bn 11 February 2016
- EU sticks to ban on generics tested by GVK Bio, ends talks 06 February 2016
- Price-gouging drug executive Shkreli calls lawmakers 'imbeciles' 05 February 2016
- Bharat Biotech claims breakthrough in Zika vaccine development 03 February 2016
- US medical device maker Stryker to buy Sage Products for $2.78 bn 02 February 2016
- Abbott to buy rapid diagnostic testing provider Alere for $5.8 bn 02 February 2016
- Theranos under increasing regulatory fire 29 January 2016
- Merck gets a $5-mn Ebola vaccine shot from Vaccine Alliance 22 January 2016
- US biopharmaceutical company Xenoport explores sale 22 January 2016
- Price gouger Martin Shkreli lashes out at opponents on Twitter 21 January 2016
- Johnson & Johnson to cut 3,000 jobs in its medical devices unit 20 January 2016
- Drugs may get cheaper with 35% cap on trading margin 19 January 2016
- Drug trials in France leave 1 brain-dead, 5 critical 16 January 2016
- Shire to buy US biotech firm Baxalta for $32 bn 12 January 2016
- Aurobindo Phrma to set up plant in S Arabia 11 January 2016
- States told to be vigilant against online drug sales 05 January 2016
- Shire Plc in advanced talks to acquire Baxalta: reports 04 January 2016
- Cadilla Healthcare shares slump after US warning 31 December 2015
- Cancer, HIV drugs among 106 added to essential list 26 December 2015
- KaloBios Pharma fires CEO Martin Shkreli 22 December 2015
- Martin Shkreli rejects charges 21 December 2015
- Business survival forces Isis Pharma to rename itself 21 December 2015
- Drug price gouger Martin Shkreli resigns from Turing Pharmaceuticals 21 December 2015
- AstraZeneca boost oncology portfolio with $4bn Acerta Pharma deal 17 December 2015
- After Australia, UK's ASA to probe Reckitt Benckiser's Nurofen claim 15 December 2015
- Natco, partner settle patent suit over Gilead's Tamiflu 15 December 2015
- Office of drugs controller suspends 53 licenses in Kashmir valley 14 December 2015
- Sun Pharma in pact to develop brain stroke drug 11 December 2015
- Mexico approves world's first anti-dengue vaccine 11 December 2015
- Govt to soon launch bulk drug/medical equipment parks 09 December 2015
- Sun Pharma gets US nod for generic leukemia drug 05 December 2015
- Injectable vaccine to prevent polio re-emergence launched 30 November 2015
- Turing Pharma halves Daraprim price hike from 5,000% to 2,500% 27 November 2015
- FDA threatens Dr Reddy's with US import ban 26 November 2015
- Turing does volte face on cutting price of drug Daraprim 26 November 2015
- Shire preparing to mount new bid for Baxalta 25 November 2015
- US politicians unite to flay Pfizer-Allergan deal 24 November 2015
- Pfizer to take over Allergan in historic $150-bn deal 23 November 2015
- NIH announces end to support for invasive research on chimpanzees 21 November 2015
- Pfizer said to be in $150-bn merger talks with Allergan 19 November 2015
- Sun Pharma in talks to buy Novartis' Japan portfolio 14 November 2015
- FDA seeks third-party audit of all Dr Reddy's plants 10 November 2015
- Gilead wins US FDA nod for TAF-based HIV drug 10 November 2015
- AstraZeneca to buy ZS Pharma for $2.7 bn 06 November 2015
- IPC set to become first WHO Collaborating Centre in SE Asia 05 November 2015
- Ipca to make open offer for 26% stake in Krebs on 9 November 04 November 2015
- Rampant use of antibiotics hurting India badly 04 November 2015
- Sun Pharma completes acquisition of InSite Vision 03 November 2015
- French drug maker Sanofi recalls epinephrine injectors 02 November 2015
- UK surgeons use cow parts to save baby's life 02 November 2015
- UK bans eyecare ad claiming blue light is harmful 30 October 2015
- Pfizer, Allergan mull largest pharma merger 29 October 2015
- Walgreens to buy smaller drugstore rival Rite-Aid for $9.4 bn 28 October 2015
- Surgical device infections cause deaths at Pennsylvania hospital 28 October 2015
- Merck overhauls brand identity to communicate new direction 17 October 2015
- Drug retailers protest; demand closure of e-pharmacies 15 October 2015
- Eli Lilly's stock hit after evacetrapib study ended 13 October 2015
- J&J launches clinical trial of preventive Ebola vaccine regimen 09 October 2015
- US nod for 'breakthrough' lung cancer drug 06 October 2015
- Youyou Tu's herbal therapy for malaria wins Nobel for medicine 06 October 2015
- Teva to buy Mexican drugmaker Rimsa for $2.3 bn 03 October 2015
- US FDA rescinds approval for Sun Pharma's epilepsy drug Elepsia XR 26 September 2015
- Pfizer sells Thane plant to Vidhi Research for Rs178 cr 23 September 2015
- Turing vows to cut Daraprim drug price after furore over 5,000% hike 23 September 2015
- Sanofi, Pfizer, Abbott eye Mexican generic drug maker Rimsa 21 September 2015
- Sun Pharma sells two Ranbaxy units to Strides Arcolab 21 September 2015
- India among worst abusers of antibiotics 19 September 2015
- Sun Pharma to acquire US firm InSite Vision for $48 mn 18 September 2015
- Dental supply firm Dentsply to acquire Sirona in $5.5-bn deal 16 September 2015
- Suven Life secures 2 product patents in Canada, 1 in China 16 September 2015
- FSSAI bars selling of health supplements as medicines 14 September 2015
- AstraZeneca acquires Amgen's biologics unit in US 11 September 2015
- India's drug board brings cheer to animal lovers 09 September 2015
- Anti-smoking drug varenicline safer than previously thought 08 September 2015
- Indian Patent Office rejects Pfizer's claim for arthritis drug patent 07 September 2015
- Cipla to acquire 100% stake in two US generic drug firms for $550 mn 04 September 2015
- US FDA approves AstraZeneca's new dosage for heart drug 'Brilinta' 04 September 2015
- Valeant to buy rights to AstraZeneca's psoriasis drug 01 September 2015
- Godrej Agrovet to buy 45.29% in Astec LifeSciences 31 August 2015
- Mylan shareholders back plan for Perrigo hostile bid 29 August 2015
- Germany suspends more drugs tested by GVK Bio 22 August 2015
- Roche to buy GeneWEAVE BioSciences 14 August 2015
- Cabinet okays Rs1,750-cr move to strengthen drug regulation 13 August 2015
- Ban on GVK drugs due to 'inadequate data': EU regulator 08 August 2015
- San Francisco to deliver medicinal marijuana by drones 06 August 2015
- India defers FTA talks with EU over GVK ban 05 August 2015
- US FDA approves first 3D printed pill 05 August 2015
- Baxalta rejects drugmaker Shire's approach 05 August 2015
- Dr Reddy's Q1 net up 14% at Rs626 crore 30 July 2015
- Lupin buys US generics drug maker Gavis for $880 mn 23 July 2015
- Valeant to buy Egyptian drugmaker Amoun for $800 mn 18 July 2015
- NPPA brings 39 more medicines under price control 16 July 2015
- Celgene to buy drugmaker Receptos for $7.2 bn 15 July 2015
- US claims $3.3 bn in Novartis kickback lawsuit 01 July 2015
- Drugmaker Valeant bids for animal health firm Zoetis 26 June 2015
- Eli Lilly wins key cancer drug patent case in UK 26 June 2015
- Government launches pharma price data bank 25 June 2015
- Abbott Laboratories to back Mylan-Perrigo deal 17 June 2015
- Teva settles US antitrust charges for $1.2 bn 29 May 2015
- Biocon Q4 net profit surges 78% to Rs202 cr 30 April 2015
- Perrigo rejects Mylan's latest $34.10 bn bid 30 April 2015
- Mylan raises bid for Perrigo Co to $34.10 bn 29 April 2015
- Perrigo Co rejects Mylan's $33-bn sweetened bid 25 April 2015
- AstraZeneca,Juno partner to study immune therapy drugs 24 April 2015
- Perrigo rejects Mylan's $29 bn takeover offer 22 April 2015
- Teva Pharmaceutical offers to buy Mylan NV for $40 bn 22 April 2015
- Daiichi Sankyo begins selling its stake in Sun Pharma 21 April 2015
- Glenmark to raise Rs 945 crore from Temasek Holdings 17 April 2015
- Generic drug maker Mylan bids for Perrigo Co for $29 bn 09 April 2015
- Govt reviewing FDI policy in pharma sector: report 30 March 2015
- Sun, Ranbaxy complete $4-bn merger 24 March 2015
- CCI okays Shashun Pharma-Strides Arcolab merger 24 March 2015
- Wockhardt revamps quality control team on FDA demand 20 March 2015
- HC blocks Glenmark from selling US firm's diabetes drug 20 March 2015
- Valeant Pharma raises Salix bid to $11.1 bn 16 March 2015
- Valeant Pharma plans to raise bid for Salix 14 March 2015
- Sun-Ranbaxy merger deal nears closure with HC nod 09 March 2015
- FDA approves first biosimilar drug for US sales, Zarxio 07 March 2015
- Sun Pharma to buy Glaxo's Australian opiates business 03 March 2015
- Medical scope linked to deadly bacterial outbreak 20 February 2015
- Sun's Shanghvi reported in talks with Tanti for Suzlon stake 13 February 2015
- AstraZeneca acquires Actavis's respiratory business for $600 million 06 February 2015
- Mylan to buy Famy women's healthcare business 03 February 2015
- Sun Pharma buyout of Ranbaxy gets conditional US nod 31 January 2015
- Study rebuts claims of Tamiflu being a mere placebo 30 January 2015
- Study links common over-the-counter drugs to dementia 28 January 2015
- Médecins slams Gilead for licencing new hepatitis drug in India 28 January 2015
- European regulator bans drugs from GVK's Hyderabad plant 24 January 2015
- Another US FDA blow: Ipca imports from Ratlam plant banned 23 January 2015
- Piramal to soon acquire US injectables maker Coldstream 19 January 2015
- Cipla appeals HC order barring sales of cheap lung drug 14 January 2015
- Roche to acquire Foundation Medicine in a $1-bn deal 13 January 2015
- AmerisourceBergen to acquire MWI Veterinary Supply for $2.5 bn 13 January 2015
- Shire acquires specialty drug maker NPS Pharma for $5.2 bn 12 January 2015
- HC backs Novartis, bars Cipla from selling lung drug copy 10 January 2015
- 3 Indian firms get FDA nod to sell generic hypertension drug 07 January 2015
- Walgreens completes Alliance Boots acquisition 03 January 2015
- Novartis-GSK business deal gets CCI nod 23 December 2014
- Roche to buy Austrian biotechnology company Dutalys in $489 mn deal 20 December 2014
- Price control extended to 617 drugs, more to follow: Ananth kumar 20 December 2014
- Dr Reddy's acquires quit-tobacco patch Habitrol from Novartis 19 December 2014
- Shire weighs bid for rare disease specialist NPS Pharmaceuticals 18 December 2014
- Philips to buy medical device maker Volcano Corp for $1.2 bn 17 December 2014
- Biocon plans to set up manufacturing unit in Visakapatanam 15 December 2014
- India brings another 52 drugs under NPPA price control 13 December 2014
- Cadila launches cut-rate version of expensive arthritis drug 10 December 2014
- Merck & Co to buy Cubist Pharmaceuticals for $8.4 bn 10 December 2014
- Sun Pharma, Ranbaxy merger deal gets conditional CCI nod 09 December 2014
- EU regulators disapprove GVK Bio's clinical trials 06 December 2014
- Aurobindo Pharma completes $132.5-m acquisition of US firm Natrol 06 December 2014
- GSK abandons sale of older drugs portfolio 05 December 2014
- After US, Germany bans Ranbaxy antibiotic from Dewas plant 04 December 2014
- GlaxoSmithKline's $1.57-bn restructuring to hit US jobs 04 December 2014
- European regulator approves Medtronic-Covidien $42.9-bn deal 28 November 2014
- Ebola virus gives birth to a new vaccine 28 November 2014
- Medtronic's $42.9-bn Covidien deal approved by US regulator 27 November 2014
- Bayer weighs sale of diabetes device business worth up to $2.5 bn 25 November 2014
- Tata Memorial recommends 12 cancer drugs for price control 25 November 2014
- US court dumps Ranbaxy's bid to stall launch of rival generics 20 November 2014
- Ranbaxy sues US FDA over revoking drug approvals 18 November 2014
- Indian pharma companies well positioned for global growth: S&P 12 November 2014
- Botox maker Allergan in talks with new suitor 07 November 2014
- AstraZeneca strikes three oncology deals 04 November 2014
- Wockhardt Q2 net plunges 97% on US export ban 04 November 2014
- Cipla wants Novartis's patents on respiratory drug revoked 30 October 2014
- CSL to acquire Novartis' influenza vaccine unit 27 October 2014
- Fujifilm to buy 49% in Texas-based Kalon Biotherapeutics 27 October 2014
- Eli Lily to divest US veterinary assets to Virbac 27 October 2014
- AbbVie calls off $55-bn acquisition of Shire over US tax rules 22 October 2014
- HIV 'wonder drug' may be made available on NHS in UK 18 October 2014
- Ranbaxy made to pay $40mn to settle pricing litigation in US 16 October 2014
- AbbVie to reconsider $55-bn Shire deal 15 October 2014
- Novartis fined Rs300 crore for overpricing painkiller Voveran 13 October 2014
- Suven Life secures product patent in S Korea, US 13 October 2014
- Valeant Pharmaceuticals plans to raise bid for Allergan 08 October 2014
- Price cap on 108 “non-essential“ drugs lifted as govt reverses stance 23 September 2014
- Canadian regulator asks Ipca to stop API exports 22 September 2014
- Indian Pharma regulator cuts prices of 43 drug formulations 19 September 2014
- Ranbaxy grilled by US Justice Dept over Medicaid drug pricing 18 September 2014
- US judge upholds Ranbaxy-Pfizer Lipitor marketing deal 13 September 2014
- Lupin ties up with Salix to sell US firm's drugs in Canada 13 September 2014
- Sun Pharma hopes to turn around Ranbaxy in four years of closing deal 12 September 2014
- Strong US generic market lifts pharma growth 11 September 2014
- FTC sues AbbVie, Teva over AndroGel delay 09 September 2014
- Competition panel seeks public comments on Sun-Ranbaxy merger deal 04 September 2014
- Generic asthma inhaler drug breathes fresh life into Cipla 03 September 2014
- CCI worried about 'molecular' effect of Sun-Ranbaxy merger 30 August 2014
- New study raises hopes of drug treatment for Ebola 30 August 2014
- Sun-Ranbaxy merger: competition panel demands more details 28 August 2014
- Roche to buy InterMune for $8.3 bn 25 August 2014
- Sun Pharma unit recalls Cephalexin capsules in US market 16 August 2014
- Pfizer hit with lawsuits over Lipitor 11 August 2014
- Pharma industry not happy with new drug price controls 09 August 2014
- Sanofi Emcure in pact to market oncology drugs 06 August 2014
- Drug resistance to malaria increasing warn experts 31 July 2014
- Transparency lacking in clinical trials: study 31 July 2014
- Reckitt Benckiser to spin off pharma business 28 July 2014
- GlaxoSmithKline to launch first-ever malaria vaccine 26 July 2014
- Shire's board agrees to £32-bn takeover by AbbVie 18 July 2014
- Cipla to acquire 51% stake in Yemeni pharma firm 30 June 2014
- India may extend price control to more drugs 25 June 2014
- Collectis shares surge on Pfizer deal 19 June 2014
- Valeant starts hostile takeover process for Allergan 19 June 2014
- Japan's Mieji Holdings buys out Medreich for $290 mn 12 June 2014
- EU lifts ban on Ranbaxy's Toansa-made drugs 06 June 2014
- Stryker denies Smith & Nephew bid 29 May 2014
- Pfizer drops AstarZeneca take over bid 28 May 2014
- SC blasts manner of stalling Sun-Ranbaxy merger 21 May 2014
- GSK's former China head charged with bribery 14 May 2014
- AstraZeneca snubs Pfizer's “opportunistic“ bid 13 May 2014
- AstraZeneca to consider Pfizer's $106-bn bid 02 May 2014
- Allergan set to approach Shire Plc once again: report 29 April 2014
- Forest Labs to buy GI specialist Furiex in $1.46-bn deal 28 April 2014
- Greater investment needed to check malaria: WHO 25 April 2014
- Novartis AG, GSK in $23-bn assets swap deal 22 April 2014
- Pfizer weighs $101-bn bid for AstraZeneca 21 April 2014
- Suven Life secures new patents in Canada, Hong Kong 10 April 2014
- Ranbaxy drug flows to Europe, US to dry up 09 April 2014
- GSK launches probe into unethical conduct in Iraq 09 April 2014
- Sun Pharma, Ranbaxy to merge in Rs24,000 all-stock deal 07 April 2014
- India ready to defend its IPR norms at WTO: Sharma 24 March 2014
- AstraZeneca confirms de-listing from Indian bourses 19 March 2014
- And now, USFDA bans imports from Sun Pharma unit 13 March 2014
- GSK spends $1.05 bn to raise stake in Indian arm 11 March 2014
- US orphan-drug maker InterMune evokes takeover interest 08 March 2014
- May collaborate, not take over Roche: Novartis 03 March 2014
- Indian generics still unsafe despite FDA efforts, US lawmakers told 27 February 2014
- Ranbaxy suspends all shipments from Toansa, Dewas plants 25 February 2014
- Eli Lilly's Elanco to buy Germany's Lohmann Animal Health 25 February 2014
- Drug CRO Medpace to be sold to European PE firm Cinven for $915 mn 25 February 2014
- Bayer close to bagging cancer drug maker Algeta for $2.9-bn 24 February 2014
- Not targeting India, but US standards must be met: FDA's Hamburg 22 February 2014
- Ranbaxy, Teva to pay $15,000 each to settle US anti-trust case 20 February 2014
- Actavis to acquire Forest Laboratories for $25 billion 19 February 2014
- India, US must work jointly for lifting FDA ban: Hamburg 19 February 2014
- FDA pushes for warnings on generic drugs 18 February 2014
- Actavis in talks to buy Forest Laboratories for around $25 bn 18 February 2014
- Novartis acquires biotechnology company CoStim Pharmaceuticals 17 February 2014
- Appeals by Indian drug firms fail to impress FDA's Hamburg 17 February 2014
- Flawed law denies European kids life-saving cancer drugs: experts 12 February 2014
- US, Indian drug authorities agree on regulatory cooperation 11 February 2014
- Cheaper drugs not necessarily spurious, India tells US FDA 11 February 2014
- Pharma MNCs seek US action against generic threat from India 06 February 2014
- FDA ban will only impact US business 10-15%: Ranbaxy 06 February 2014
- Azad gives pharma firms hopes of easing clinical trial norms 06 February 2014
- Biotech firm Biocon ties up with Baxter for new research centre 06 February 2014
- Myriad Genetics to buy Crescendo Bioscience 05 February 2014
- Lupin acquires Dutch injectable company Nanomi BV 04 February 2014
- Valeant Pharmaceuticals to buy PreCision Dermatology for $475 mn 04 February 2014
- CCI warns pharma trade against anti-competitive practices 03 February 2014
- Smith & Nephew to buy medical devices firm ArthroCare for $1.7 bn 03 February 2014
- After FDA, Ranbaxy under scanner of Indian authorities too 30 January 2014
- GVK Bio to acquire US-based CRO Aragen Bioscience 29 January 2014
- Ranbaxy hit afresh by FDA; all its India-made products banned 24 January 2014
- Quest Diagnostics to buy Solstas Lab for $570 mn 23 January 2014
- Biocon to launch breast cancer drug 'CANMAb' next month 18 January 2014
- Aurobindo Pharma to acquire Actavis's European operations 18 January 2014
- US FDA raises concerns over a fourth Ranbaxy facility 14 January 2014
- Forest Labs acquires Aptalis for $2.9 bn 09 January 2014
- Government sticks to 100% FDI in pharma takeovers 08 January 2014
- Sanofi fails to win US FDA approval for Genzyme's MS drug Lemtrada 30 December 2013
- Bayer to acquire cancer drug maker Algeta 19 December 2013
- Wockhardt's Swiss arm to list on Berne exchange today; shares spurt 19 December 2013
- GlaxoSmithKline to stop paying doctors for product promotion 17 December 2013
- Glaxo announces open offer to hike stake in Indian arm 16 December 2013
- Torrent to buy Elder's India, Nepal business for Rs2,000 crore 13 December 2013
- US firm Mylan buys out Stride Arcolab's injectables unit 06 December 2013
- No non-compete clause in pharma sector takeovers: govt 02 December 2013
- Cabinet refuses to peg pharma sector FDI at 49% 29 November 2013
- US buyout firm KKR to invest $200 mn in Gland Pharma 28 November 2013
- Biocon, Mylan get approval for biosimilar cancer drug Trastuzumab 28 November 2013
- US group opposes Gilead's patenting of hepatitis C drug in India 25 November 2013
- Pfizer India and Wyeth Ltd to merge Indian operations 25 November 2013
- Government to review FDI policy in pharma, realty 23 November 2013
- PE firms in fray for critical care biopharma firm Ikaria 23 November 2013
- US FDA warns Medtronic's recalled guidewires could cause death 18 November 2013
- Commerce ministry bats for limiting pharma FDI at 49% 15 November 2013
- Sun Pharma Q2 net jumps four-fold to Rs1,362 crore 14 November 2013
- Boehringer Ingelheim in the race to buy Lohmann Animal Health 09 November 2013
- Salix Pharmaceuticals to buy Santarus for $2.6 billion 08 November 2013
- Endo Health to buy Canada's Paladin Labs in $1.7-bn deal 06 November 2013
- Mis-selling of drugs to cost J&J $2.2 bn in US settlement 05 November 2013
- Roche to pay $458 mn for rights to experimental antibiotic 05 November 2013
- Wockhardt faces fresh strictures from UK drug regulator 23 October 2013
- Reckitt Benckiser prepares to sell pharmaceuticals unit 23 October 2013
- Actis invests Rs294 crore in Indore's Symbiotec Pharmalab 23 October 2013
- Wockhardt recalls 5 drugs in UK after regulatory strictures 19 October 2013
- Hungary, India sign pact to promote Ayurveda 18 October 2013
- Wockhardt gets another slap from UK drug regulator 14 October 2013
- German nicotine-patch maker LTS Lohmann receives several bids 12 October 2013
- KKR & Co to buy 30% in Gland Pharma for Rs920 crore: report 11 October 2013
- Teva Pharmaceutical to cut 5,000 jobs, save $2 bn annually 11 October 2013
- Indigenous vaccine for Japanese encephalitis launched 05 October 2013
- US biopharmaceutical company Ikaria Inc explores sale 04 October 2013
- PE firms in race for J&J's Ortho Clinical Diagnostics unit 01 October 2013
- GSK sells thrombosis drugs to Aspen for $1.13 billion 01 October 2013
- Supreme Court bans all drug trials for lack of monitoring mechanism 30 September 2013
- Wockhardt gets another blast from US drug regulator FDA 28 September 2013
- US medical device maker Stryker Corp to buy Mako Surgical for $1.65 bn 26 September 2013
- Apollo, Saarum Innovations team up to set up biobank 24 September 2013
- Ablynx in $840-mn drug licensing deal With AbbVie 23 September 2013
- Roche denies raising money to acquire BioMarin Pharmaceuticals 20 September 2013
- Southeast Asian generics market to reach $3.9 bn by 2016 16 September 2013
- Sanofi, Shire eye US rare diseases drug maker ViroPharma 14 September 2013
- S African drug maker Adcock Ingram approves Chile's CFR $1.3-bn bid 12 September 2013
- KKR & Co may invest Rs1,000 cr in Hyderabad-based Gland Pharma 10 September 2013
- J&J launches sale of Ortho Clinical Diagnostics unit 07 September 2013
- Amgen to acquire cancer drug maker Onyx for $10.4 bn 26 August 2013
- German generic drugmaker Stada to buy UK's Thornton & Ross 17 August 2013
- Amgen's $9.5-bn Onyx deal stumbles over cancer drug data 16 August 2013
- Mylan gets PMO nod to acquire Agila Specialities 16 August 2013
- CFR's $1.3-bn bid remains best offer for Adcock Ingram 16 August 2013
- Rexam starts selling $1 bn healthcare packaging unit 14 August 2013
- Sun Pharma does well, but Pfizer settlement puts it in red 10 August 2013
- Amgen said to raise bid for Onyx Pharma to $130 a share 07 August 2013
- SC slams government for poor drug pricing policy 07 August 2013
- Nova Diabetes Care recalls 62 mn faulty glucose test strips 02 August 2013
- India revokes patent of GSK's breast cancer drug Tykerb 02 August 2013
- KKR & Co to buy ReSearch Pharmaceutical from PE firm Warburg 01 August 2013
- Pharma giants target biotech firm Onyx 23 July 2013
- China detains four senior GSK employees over bribery 15 July 2013
- Sun Pharma gets US nod to sell generic diabetes drug 13 July 2013
- Swiss drugmaker Roche eyes Alexion Pharmaceuticals 13 July 2013
- British drug regulator recalls 16 Wockhardt drugs 11 July 2013
- DIPP throws spanner in 100% pharma sector FDI plan 06 July 2013
- China launches probe on GSK over price fixing 05 July 2013
- Valeant to acquire Bausch & Lomb for $8.7 bn 27 May 2013
- Merck & Co to buy back $5-bn worth stock 22 May 2013
- 3i makes a 2.3x return on the sale of Xellia 21 May 2013
- Actavis rejects Mylan's $15-bn offer 15 May 2013
- IISc develops novel drug delivery device 08 May 2013
- AstraZeneca site to emerge as biotech hub 08 May 2013
- Valeant Pharma's $13-bn Actavis deal put on hold 29 April 2013
- Russia blocks Abbott Laboratories - Petrovax merger 20 April 2013
- Eli Lilly to lay off around 1,000 sales personnel in US 12 April 2013
- Astellas in oncology antibody drug pact with Ambrx 05 April 2013
- DRL founder-chairman Anji Reddy passes away 15 March 2013
- Bayer loses cancer drug patent case 04 March 2013
- Strides Arcolab sells Agila Specialties to Mylan for $1.6 bn 28 February 2013
- FDA turns down Reckitt's bid to block rival products 27 February 2013
- Royalty Pharma launches $6.6 bn bid for Irish drug maker Elan Corp 26 February 2013
- GSK Pharma net up at Rs138.5 cr; proposes 500 per cent dividend 19 February 2013
- Andhra HC quashes tax demand on Sanofi over Shantha Biotech buyout 15 February 2013
- US generic drug maker Perrigo acquires Rosemont Pharmaceuticals 12 February 2013
- Sun Pharma calls off $600-million buyout of Taro 08 February 2013
- CVS Caremark buys Brazilian drugstore chain Drogaria Onofre 07 February 2013
- GSK ups stake in Indian arm to 72.5% in a Rs4,800-cr stock deal 05 February 2013
- Bristol-Myers Squibb may sell some brands in Mexico, Brazil: report 01 February 2013
- Johnson & Johnson weighs sale of Women's Health division: report 28 January 2013
- Merck to recall good HDL cholesterol drug Tredaptive 12 January 2013
- Biocon receives marketing authorisation for psoriasis drug 08 January 2013
- Humans are not guinea pigs, SC tells govt 03 January 2013
- Dr Reddy's Lab sued for patent infringement in US 27 December 2012
- Illumina reportedly agrees to Roche's $8.2-bn takeover offer 21 December 2012
- Mumbai's Transasia acquires Drew Scientific, JAS Diagnostics Inc 19 December 2012
- New EU drug export rule likely to hit pharma exports 13 December 2012
- National Pharmaceutical Pricing Policy, 2012 to replace DPCO 12 December 2012
- Amgen to buy Decode Genetics for $415 million 11 December 2012
- GSK, MD Anderson Cancer Center to develop new cancer drugs 10 December 2012
- Wipro to acquire Singapore's LD Waxson Group for Rs790 crore 08 December 2012
- Strides Arcolab, Eli Lilly to collaborate on cancer drug delivery 05 December 2012
- AstraZeneca loses appeal on lung cancer drug rights in India 28 November 2012
- Smith & Nephew to buy privately-held Healthpoint for $782 million 28 November 2012
- Pfizer cuts Viagra price in Canada after losing patent case 23 November 2012
- Essential drug prices to fall as GoM approves new pricing policy 22 November 2012
- Canadian life sciences company SQI Diagnostics explores sale 20 November 2012
- Allergan to buy SkinMedica's skin care unit for $350 million 19 November 2012
- GVK BIO sets up India's largest lsotope labeling facility 19 November 2012
- Biocon in pact with Bristol-Myers Squibb for oral insulin 16 November 2012
- Boston Scientific to buy Vessix Vascular in a $425 million deal 09 November 2012
- Cipla slashes prices of three more cancer drugs 08 November 2012
- Allergan explores sale of obesity intervention business 31 October 2012
- Pfizer to buy ADHD drug maker NextWave Pharma for $255 mn 22 October 2012
- SC asks centre, states to explain “illegal“ human drug trials 08 October 2012
- Government proposes free supply of essential medicines: Azad 03 October 2012
- SC rejects govt's new drug pricing proposals 03 October 2012
- Sanofi to acquire Colombian affordable drugmaker Genfar 03 October 2012
- NGO to challenge drug price control over lacunae 29 September 2012
- Government to cap prices of essential drugs 28 September 2012
- Medtronic to acquire orthopaedic device maker China Kanghui for $816 mn 28 September 2012
- Canada's Valeant Pharma acquires QLT's Visudyne for over $112.5-mn 25 September 2012
- Biocon among top 20 employers in sector: survey 25 September 2012
- PE firm Advent to buy Dutch pharmacy chain Mediq for $1.01 bn 24 September 2012
- Mitsui's stake buy in Arch Pharma gets CCI nod 22 September 2012
- Boston Scientific to acquire heart device maker BridgePoint Medical 20 September 2012
- Ranbaxy to invest $40 million to set up a second plant in Malaysia 13 September 2012
- Supreme Court asks Novartis to cut price of Glivec 13 September 2012
- Government approves 8 new pharma FDI proposals worth Rs1,843 crore 11 September 2012
- Glivec is `special', Novartis argues in Supreme Court 11 September 2012
- USFDA approves Aurobindo Pharma's hypertension drugs 07 September 2012
- Hiring freeze in pharma industry expected: survey 06 September 2012
- Canada's Valeant to acquire Medicis Pharmaceutical for $2.6 bn 04 September 2012
- German maker of thalidomide apologises, after 50 years 01 September 2012
- Medical technology firm ConvaTec to buy 180 Medical Holdings for $321 mn 01 September 2012
- Aetna to buy Coventry Healthcare in $5.7-bn deal 22 August 2012
- Wockhardt to launch generic hypertension drug in US 21 August 2012
- GSK to sell Australian generic portfolio to Aspen Pharma 16 August 2012
- Pfizer files IPO for animal health unit Zoetis Inc 14 August 2012
- Sun Pharma to buy out Israel's Taro for $571 million 13 August 2012
- Pfizer to pay $60 mn to settle US bribery charges 08 August 2012
- Ranbaxy in licensing pact with Gilead for HIV drug 03 August 2012
- India weighing price controls on patented drugs 27 July 2012
- Israel's Teva, P&G tie up to set up plant in Gujarat 25 July 2012
- India's role in AIDS control commended 19 July 2012
- Biocon plans merger with biopharma subsidiary 18 July 2012
- USFDA revokes warning to Cadila Healthcare 17 July 2012
- Finoso Pharma forms equal JV with US-based CritiTech 13 July 2012
- Strides Arcolab forms JV with Canada's Jamp Pharma 11 July 2012
- Government to set up fund for pharma R&D 04 July 2012
- Daiichi Sankyo to market Ranbaxy drugs in Venezuela 20 June 2012
- Cipla to slash prices of six more cancer drugs 11 May 2012
- Cipla slashes prices of three key cancer drugs 03 May 2012
- AstraZeneca buys US biotech firm Ardea for $1.26 bn 24 April 2012
- Baxter to set up $1-bn plant for plasma-based therapies 21 April 2012
- Aspen to buy GSK's international OTC brands 20 April 2012
- Roche ends $6.7-bn hostile bid for Illumina 19 April 2012
- Letter to Roche from Illumina's president and CEO 03 April 2012
- Illumina rejects Roche's $6.7-bn bid 03 April 2012
- Dow Chemicals to eliminate 900 jobs, shutter four plants 02 April 2012
- Ranbaxy begins US exports of generic Lipitor from Mohali 02 April 2012
- Amylin reportedly rejects Bristol-Myers $3.5-bn bid 30 March 2012
- Roche asks Illumina investors to accept its $5.7-bn bid 21 March 2012
- GSK to sell most European OTC drugs to Omega Pharma 15 March 2012
- Natco granted compulsory licence for Bayer's Nexavar 12 March 2012
- Ranbaxy opens new manufacturing facility in Morocco 12 March 2012
- Asahi Kasei makes $2.2-bn bid for Zoll Medical 12 March 2012
- Roche extends hostile $5.7-billion offer for Illumina 27 February 2012
- Ranbaxy may hand over Latin American marketing to Daiichi Sankyo 25 February 2012
- Ranbaxy reports Rs2,983 crore Q4 loss on US probe provisioning 23 February 2012
- Mexico's Genomma to buy Prestige Brands for $834 million 22 February 2012
- Rejected in the US, J&J sells hip implant overseas 16 February 2012
- Merck, Brazil's Supera Farma to form JV for generic drugs 16 February 2012
- Valeant to acquire Macugen anti-VEGF inhibitor maker Eyetech Inc 14 February 2012
- Illumina rejects Roche's $5.7- bn hostile bid 08 February 2012
- GSK repatriating funds daily from European operations 08 February 2012
- AstraZeneca eliminates 7,300 jobs in major restructuring 03 February 2012
- Pfizer recalls 1 million birth-control pills 01 February 2012
- Roche Diagnostics plans Jafza headquarters for Middle East 30 January 2012
- Outlook for pharmaceutical in 2012 stable, says Fitch 30 January 2012
- Amgen to buy leukemia drug developer Micromet for $1.16 billion 27 January 2012
- Novartis restructures US operations, to cut 1,960 jobs 14 January 2012
- Glenmark wins favourable interim order in deal with Napo 14 January 2012
- Alexion Pharma to acquire Enobia for around $1.08 bn 29 December 2011
- Zydus Cadila acquires Biochem Pharmaceuticals 21 December 2011
- Medical device maker C R Bard acquires Lutonix 21 December 2011
- Ranbaxy to pay $500 million to settle USFDA ban 21 December 2011
- Government extends sops for engineering, pharma and chemical exports 16 December 2011
- Covidien plans to spin off pharmaceuticals business 16 December 2011
- Glenmark to market Crofelemer despite Napo nix 15 December 2011
- AstraZeneca to buy China's generic maker Guangdong BeiKang Pharma 08 December 2011
- AstraZeneca to cut 1,150 sales jobs in the US 08 December 2011
- Ranbaxy to share Lipitor profits with Teva 02 December 2011
- No immediate gain for Ranbaxy despite Lipitor patent's expiry 30 November 2011
- Unlimited FDI in pharma sector worries Jena 30 November 2011
- Merck to pay $950 million to settle Vioxx drug charges 24 November 2011
- Pfizer to buy skin scarring drugmaker Excaliard Pharmaceuticals 23 November 2011
- Pfizer to settle bribery charges with US government: report 21 November 2011
- Lupin to acquire Japan's I'rom Pharmaceutical 17 November 2011
- Drugmakers Otsuka, Lundbeck form global alliance for five drugs 11 November 2011
- Pfizer, Ranbaxy sued over Lipitor price fixing in the US 10 November 2011
- Salix Pharmaceuticals to buy Oceana Therapeutics for $300 million 09 November 2011
- European countries sign treaty to combat fake drugs 31 October 2011
- AstraZeneca - Bristol-Myers to present new data on diabetes drug 27 October 2011
- Novartis to eliminate 2,000 jobs, close two sites in Europe 25 October 2011
- Abbott to pay $1.3 bn to settle Depakote epilepsy drug claims 24 October 2011
- Abott to split into two 19 October 2011
- Roche to buy hepatitis C drug developer Anadys for $230 million 18 October 2011
- J&J unit wins lawsuit over antibiotic Levaquin drug side effects 15 October 2011
- Merck & Co sells OTC joint venture to Johnson & Johnson for $175 million 29 September 2011
- Ipca Labs looks to acquire pharma unit in Indonesia 28 September 2011
- Patented drugs overpriced, admits Glaxo CEO Witty 28 September 2011
- JB Chemicals, Dr Reddy's call of Russia-CIS business deal 26 September 2011
- Johnson & Johnson recalls anaemia drug Eprex in 17 countries 24 September 2011
- New trial for retinal stem cell treatment approved 23 September 2011
- Sun Pharma resolves FDA issue at US plant 19 September 2011
- Jubilant arm in $70-million OTC drug manufacturing contract with US firm 14 September 2011
- S Africa's Aspen Pharma targets $800-mn foreign acquisitions 14 September 2011
- India to emerge among top players in pharma industry by 2020 13 September 2011
- Biocon to set biopharmaceutical plant, R&D centre in Malaysia 12 September 2011
- Ranbaxy to launch generic 'Lipitor' in US by November 09 September 2011
- Lupin, Sanofi-Aventis Philippines in strategic agreement 05 September 2011
- Ranbaxy's subsidiary launches esomeprazole in UK 05 September 2011
- US drug standards agency expands testing facility in India 02 September 2011
- Dr Reddy's launches OTC generic of Sanofi's Allegra 31 August 2011
- Cipla, Lupin deny in stake sale talks with Takeda 25 August 2011
- Google settles Canadian pharma ad probe for $500 mn 25 August 2011
- Aventis Pharma to acquire Universal Medicare in India 25 August 2011
- Sanofi plans Rs450-cr OTC deal with Universal Medicare 23 August 2011
- Panacea loses drug contract with WHO over quality issues 19 August 2011
- Ipca Labs buys UK-based Onyx Research Chemicals 09 August 2011
- Venus Remedies' novel drug for 'superbug' granted US patent 03 August 2011
- Merck & Co to axe 13,000 more jobs by 2015 30 July 2011
- HCL, Eli Lilly open Co-Innovation Lab in Singapore 14 July 2011
- UK acitivists cry foul as animal experiments rise 14 July 2011
- Orchid shuts Alathur plant on pollution concerns 12 July 2011
- US FDA slaps ban on Dr Reddy's Mexico products 07 July 2011
- Novo Nordisk to pay $25 million to settle US probe 13 June 2011
- Mylan to rename Matrix Lab as 'Mylan' 27 May 2011
- Sanofi-Aventis shortens name to Sanofi 07 May 2011
- Taro Pharma challenges Suven's ANDA in US court 06 May 2011
- Cipla posts lower Q4 net profit of Rs214 crore 06 May 2011
- Ranbaxy in settlement talks with USFDA: Reports 05 May 2011
- Strides oncology facility gets US FDA approval 02 May 2011
- Biocon to divest stake in Germany's AxiCorp 28 April 2011
- Sun to co market Merck's Diabetes drugs in India 25 April 2011
- UK government sues Reckitt Benckiser for £90 mn 18 April 2011
- J&J may buy Synthes in $20-bn deal 16 April 2011
- Merck, Sun Pharma in generics JV 11 April 2011
- New drug resistant bugs worry health experts 08 April 2011
- Regulator hikes prices of domestic insulin, TB drugs 17 March 2011
- Mount Kellet, others to buy 35 per cent stake in MedPlus 14 March 2011
- HC nod for winding up Wockhardt; company to appeal 12 March 2011
- Merck hopes to be among top-five drugmakers in India 11 March 2011
- Licences for 11 drug formulations withdrawn 09 March 2011
- Dr Reddy's targets $1 bn revenue from generics 07 March 2011
- Daiichi Sankyo acquires US cancer drug firm Plexxikon 02 March 2011
- Forest Laboratories to acquire Clinical Data for $1.2 billion 23 February 2011
- Boston Scientific introduces new stent systems in India 18 February 2011
- Mylan gains 180-day marketing exclusivity on Pfizer's Vfend generics 16 February 2011
- Lincoln Pharmaceuticals launches long-acting paracetamol 08 February 2011
- US court lifts stay on Dr Reddy's generic allergy drug 01 February 2011
- Ranbaxy, Russian region sign MoU on healthcare cooperation 31 January 2011
- Amgen to acquire BioVex Group Inc for up to $1 billion 25 January 2011
- Generic drugmaker Perrigo to buy Paddock Lab assets for $540 mn 20 January 2011
- Amrutanjan to form JV with Austin Chemical of US 19 January 2011
- Lincoln Pharma wins patent for nasal spray to treat vomiting 17 January 2011
- Johnson & Johnson mulls fresh assault on Smith & Nephew: report 17 January 2011
- Expert calls for war against deadly drug-resistant malaria 15 January 2011
- Sinopharm to acquire 80-% stake in Aurobindo's China subsidiary 11 January 2011
- Sanofi-Aventis, Genzyme in talks to structure $80 per share deal 08 January 2011
- Merck and Ranbaxy end drug development pact 06 January 2011
- Dr Reddy's set to face Pfizer in court over patent suit 06 January 2011
- Lupin in pact to supply TB drug to Brazil 05 January 2011
- India rejects HIV drug patent application by Abbott Laboratories 03 January 2011
- Transgene to start large-scale trials of new AIDS drug 27 December 2010
- Strides Arcolab seeks to hike stake in Pharmahealth 24 December 2010
- Two killed in gas leak at Dr Reddy's Laboratories in Hyderabad 22 December 2010
- Supercomputing research opens doors for drug discovery 22 December 2010
- Novartis plans $500 million investment in Russia 21 December 2010
- Sharon Bio-Medicine to set up new plant at Sangli in Maharashtra 16 December 2010
- GlaxoSmithKline acquires rights to Parkinson's drug from Impax 16 December 2010
- Sanofi-Aventis extends Genzyme offer, terms unchanged 13 December 2010
- Aventis to exit Chiron JV with Novartis, with Rs105-crore stake sale 13 December 2010
- J&J's McNeil unit recalls over 13 million packets of Rolaids 10 December 2010
- Strides acquires controlling stake in Inbiopro in Rs65-crore deal 09 December 2010
- India to retain generics production right under India-EU trade pact 08 December 2010
- US medical insurer Aetna to buy Medicity for about $500 million 08 December 2010
- China's Bright Food in talks to buy US vitamin retailer GNC Holdings 07 December 2010
- GlaxoSmithKline plans to acquire China's Nanjing MeiRui Pharma 02 December 2010
- SC rejects Bayer plea against generic Cipla drug 02 December 2010
- GSK plans to invest £500 million in new projects in UK 01 December 2010
- Cardinal Health acquires Chinese drug distributor for $470 million 01 December 2010
- US FDA grants tentative approval for Sun's generic Aricept 30 November 2010
- Indo-EU deal on drug seizures, FTA likely soon 30 November 2010
- Strides Arcolab rebrands specialities business as Agila Specialties 25 November 2010
- Solvay Pharma to merge with Abbott India in a 3:2 share swap 25 November 2010
- Medtronic to buy hypertension treatment firm Ardian for $800 million 23 November 2010
- J&J recalls Benadryl, Motrin 23 November 2010
- Claris Lifesciences Rs300 crore IPO set at Rs278-293 a share 22 November 2010
- Boston Scientific acquires Sadra Medical for $386 mn 20 November 2010
- Roche to axe 4,800 jobs in $2.1-b restructuring 17 November 2010
- Merck aims for top slots in seven emerging markets 15 November 2010
- GlaxoSmithKline expands research collaboration with Brazil's Fiocruz 13 November 2010
- Suven Life to unveil new drug candidates at US neuroscience meet 12 November 2010
- Ranbaxy registers 168 per cent leap in end-Sept profit 12 November 2010
- Eli Lilly's $800-mn Avid deal boosts diagnostic capabilities 09 November 2010
- World's first mechanical LVAD transplant performed 02 November 2010
- Drug controller brings in new rules to curb antibiotics abuse 30 October 2010
- Researchers moot proton therapy as future cancer treatment 30 October 2010
- Biocon to invest $161 million in Malaysian biotech firm 28 October 2010
- New vaccine holds promise of polio-free future 27 October 2010
- Dr Reddy's expands sales in Russia & CIS through licensing deals 25 October 2010
- Lancet's malarial estimation methodology suspect says WHO 23 October 2010
- Malaria kills 2 lakh in India every year: Lancet report 22 October 2010
- Cipla launches first generic pirfenidone in India 20 October 2010
- No standard for placebos in drug trials 19 October 2010
- Pfizer, Biocon enter into deal for biosimilar insulin 19 October 2010
- Pfizer to buy pain drug company King Pharma for $3.6 billion 12 October 2010
- Top global pharma players in fray for Paras 12 October 2010
- ImmunoGen to collaborate with Novartis on novel cancer treatment 12 October 2010
- Takeda in schizophrenia research pact with Envoy Therapeutics 09 October 2010
- India, EU resolve dispute over generic drug seizures 08 October 2010
- Scientists shed light on how serotonin works 06 October 2010
- Cheek swab may detect lung cancer 06 October 2010
- Fresenius Kabi recalls drug made by Indian arm for US sale 04 October 2010
- Sanofi-Aventis goes hostile with $18.5-bn Genzyme bid 04 October 2010
- Sun Pharma receives tentative USFDA approval for generic Crestor 30 September 2010
- GSK's diabetic drug still on sale in India as regulators dither 28 September 2010
- Sun Pharma board approves stock split into Re1 shares 24 September 2010
- Regulators in EU, US "kill" Glaxo's diabetes drug Avandia 24 September 2010
- Google sues rogue online pharmacies 23 September 2010
- GSK sues Roche over Genentech's cancer drug patent infringement 23 September 2010
- Sun acquires controlling stake in Taro, Shanghvi is chairman 22 September 2010
- Piramal starts phase-II trials for type-2 diabetes drug 22 September 2010
- Suven Life Sciences wins US patents for NCEs 21 September 2010
- Boston Scientific to buy Asthmatx for $193.5 million 21 September 2010
- Johnson & Johnson in talks to buy Crucell for $2.3 billion 17 September 2010
- Elder Pharmaceuticals to buy UK's NeutraHealth for Rs70.60 crore 17 September 2010
- Forest Labs to pay more than $313 million for selling unapproved drugs 17 September 2010
- Pharma MNCs focus on branded generics in India to drive growth 14 September 2010
- Daiichi Sankyo gets approval for influenza drugh Ianivir 13 September 2010
- Genzyme to sell genetic testing business to LabCorp for $925 million 13 September 2010
- 3M to buy patient warming products maker Arizant for $810 million 11 September 2010
- Abbott to keep Piramal business separate after acquisition 11 September 2010
- With Paras Pharma keen to sell, Emami ready to buy 09 September 2010
- Sanofi Aventis reportedly raises offer to $71 per share 09 September 2010
- Israel Supreme Court lifts injunction on Sun's acquisition of Taro 08 September 2010
- UK regulator moots withdrawing GSK's Avandia drug from UK market 06 September 2010
- Novartis aqnnounces novel antimalarial drug 06 September 2010
- GSK investigates Pandermix link to chronic sleep disorder 04 September 2010
- Orexigen, Takeda in $1-billion deal for obesity drug 03 September 2010
- Pfizer to acquire FoldRx Pharmaceuticalsing 01 September 2010
- USFDA approves Sun's generic version of Lilly's Strattera 01 September 2010
- Sanofi-Aventis reveals $18.5-billion offer for Genzyme 30 August 2010
- Aspen Pharma's A$900-million lifeline resucitates Sigma 16 August 2010
- US FDA approves Glenmark's corticosteroid 10 August 2010
- Societies to govern six AIIMS-like institutions 09 August 2010
- Genzyme begins takeover talks with Sanofi-Aventis 03 August 2010
- Capgemini acquires Skvader Systems AB 30 July 2010
- GlaxoSmithKline net sales up 9 per cent 26 July 2010
- Dr Reddys shows steady Q1 performance 23 July 2010
- GlaxoSmithKline: truth is a bitter pill 14 July 2010
- AstraZeneca scrip slumps after buy-back offer 07 July 2010
- Myanmar destroys illicit drugs worth $76 million 26 June 2010
- Dabur completes merger of Fem Care Pharma 18 June 2010
- Sun Pharma's epilepsy drug granted US FDA approval 17 June 2010
- Grifols to buy Talecris Bio for $3.4 billion 07 June 2010
- Ranbaxy recalls nerve pain drug from UK market 04 June 2010
- India's first dental stem cell bank launched 27 May 2010
- OSI accepts Astellas's $4-billion revised offer 17 May 2010
- Ranbaxy boosts Daiichi Sankyo's Q1 profits 13 May 2010
- Merck settles Zetia patent suit with Glenmark 11 May 2010
- Lupin net profit up 40 per cent in Q4 05 May 2010
- Johnson & Johnson recalls 43 children's drugs 03 May 2010
- Medtronic to acquire ATS Medical for $370 million 29 April 2010
- Glenmark launches Prasugrel for heart patients in India 29 April 2010
- GSK Q1 earnings surge on swine flue vaccine 29 April 2010
- Wockhardt launches prostate drug Flomax in the US 28 April 2010
- Indo-EU trade deal will hit drug prices: humanitarians 27 April 2010
- India to move WTO over drug seizures by EU: CNBC-TV 18 20 April 2010
- Trials of imported HPV vaccines end as six girls die 17 April 2010
- Boston Scientific to resume defibrillators sales 16 April 2010
- Ranbaxy recalls two consignments of drugs from US market 15 April 2010
- Glenmark launches two new generics in UK 07 April 2010
- Opto Circuits acquires Kokata-based N S Remedies 05 April 2010
- MDRNA acquires Cequent Pharma for $46 million 03 April 2010
- GSK, Isis Pharma in RNA therapeutics licencing pact 31 March 2010
- Ranbaxy, Dow arm tie up to develop biosimilar protein 29 March 2010
- Suven granted US patent for drug useful in CNS disorders 23 March 2010
- Abbott completes acquisition of Starlims Technologies 23 March 2010
- UB Group sells Aventis stake for Rs414 crore 23 March 2010
- Aurobindo Pharma epilepsy drug gets Canadian approval 22 March 2010
- Lupin's sleep disorder drug gets USFDA nod 22 March 2010
- Teva to acquire Germany's Ratiopharm for $5 billion 18 March 2010
- Sun Pharma gets USFDA approval for generic Prometh syrup 18 March 2010
- Boston Scientific suspends sales of seven defibrillators 17 March 2010
- MCI all set to amend Medical Ethics Regulations 13 March 2010
- Sanofi-Aventis concludes Chattem acquisition 13 March 2010
- GlaxoSmithKline on the prowl for acquisitions in India 09 March 2010
- Pfizer in bid to snap up Germany's Ratiopharm 04 March 2010
- US FDA rejects Ranbaxy's application for generic Flomax 03 March 2010
- Panacea Biotec develops Swine flu vaccine 03 March 2010
- Aurobindo gets US FDA nod for 50mg dosage of HIV drug `Nevirapine' 26 February 2010
- Ranbaxy swings back to profit 25 February 2010
- AstraZeneca settles UK tax dispute with £505 million payout 24 February 2010
- AstraZeneca India to pay 500 per cent dividend 23 February 2010
- Thermo Fisher plans to acquire Millipore for $6 billion: report 23 February 2010
- GlaxoSmithKline forced to remove zinc from denture cream products 22 February 2010
- Abbott bids for 20 per cent of Solvay India 17 February 2010
- New guidelines for doctors open to changes: MCI chief 16 February 2010
- GSK Pharma posts Q4 PAT of Rs103.59 crore 16 February 2010
- AstraZeneca inks arthritis drug deal with Rigel 16 February 2010
- CSL faces the heat as Mayo Clinic joins class action suit 15 February 2010
- US FDA approves AstraZeneca's Crestor 09 February 2010
- Scientists discover new treatment for chronic pain condition 08 February 2010
- Newly engineered enzyme is a powerful staph antibiotic 06 February 2010
- US FDA asks Ranbaxy to ensure plant standards compliance: report 05 February 2010
- Weight training improves cognitive function in seniors 05 February 2010
- Rights groups contest human gene patent in US court 04 February 2010
- Boston Scientific to pay J&J $1.73 billion in patent settlement 02 February 2010
- Cephalon to acquire Swiss generic firm Mepha for $590 million 01 February 2010
- GlaxoSmithKline may follow AstraZeneca in axing jobs: report 01 February 2010
- Lupin receives US FDA approval for perindopril erbumine tablets 29 January 2010
- Vitamin D can contribute to inflammatory bowel disease 29 January 2010
- AstraZeneca reports profit, cuts 8,000 jobs to cut costs 29 January 2010
- Widely used anti-obesity drug Sibutramine under FDA scanner 25 January 2010
- Medtronic to acquire Invatec for $350 million 25 January 2010
- Bayer to abandon haemophilia drug trial 25 January 2010
- Dr Reddy' Labs posts consolidated net loss of Rs522 crore 21 January 2010
- Alcon directors deride Novartis offer as grossly inadequate 20 January 2010
- Ranbaxy acquires Biovel to enter vaccines business 19 January 2010
- Bombay HC rejects plea to block Wockhardt deal with Abbott 18 January 2010
- J&J adds several popular brands to Tylenol recall lots 16 January 2010
- US justice dept hauls J&J to court for paying kickbacks 16 January 2010
- EC probes pharma patent settlements to stall generic launches 13 January 2010
- Ministry stays DCGI ban on Natco's generic cancer drug 11 January 2010
- GSK inching closer to deal with Dr Reddy's? 08 January 2010
- EU launches probe against Lundbeck for stalling generic drugs 08 January 2010
- Pfizer to market 40 Strides Arcolab generic drugs in the US 07 January 2010
- Wockhardt gets US FDA approval for Alzheimer's drug Memantine 06 January 2010
- Dr Reddy's all-new diabetes drug shows good results 06 January 2010
- Sun fails to dislodge Taro directors at general body 01 January 2010
- Ranbaxy sells Chinese JV stake to state-owned firm 29 December 2009
- Dr Reddy's to launch new drugs to boost domestic operations 28 December 2009
- DCGI asks GSK to withdraw promotional campaign 26 December 2009
- Ranbaxy again feels FDA heat – this time over US plant 26 December 2009
- Boston Scientific pays $22 million to settle DOJ probe on kickbacks 24 December 2009
- Novartis acquires Corthera, gets global rights to new heart drug 23 December 2009
- Glass Lewis supports Sun in Taro battle 23 December 2009
- Lupin settles dispute with Forest Labs over Namenda 22 December 2009
- Templeton cold to Taro's plea for protection against Sun 22 December 2009
- Seattle Genetics in antibody development deal with GSK 22 December 2009
- Sanofi-aventis to acquire Chattem for $1.9 billion 21 December 2009
- Ranbaxy to launch anti-hypertensive drug in six African countries 21 December 2009
- Eli Lilly wins drug patent case vs Dr Reddy's in UK 18 December 2009
- Sun Pharma advises Taro shareholders against voting at AGM 18 December 2009
- India's FY09 pharma exports up 25 per cent at Rs38,433 crore 17 December 2009
- J&J to buy ENT device maker Acclarent for $785 million 17 December 2009
- Hospira of US buys Orchid's injectables business 16 December 2009
- Abbott to acquire Starlims Technologies for $123 million 15 December 2009
- Taro again warns shareholders to stay away from Sun 12 December 2009
- GlaxoSmithkline suspends operations at Andhra unit 11 December 2009
- Glaxo targets emerging markets for acquisitions, tie-ups 11 December 2009
- Biocon, HCG hospitals team up to fight cervical cancer 10 December 2009
- EKO Diagnostics to provide PET biomarkers to Siemens in Kolkata 09 December 2009
- Ranbaxy exits JV with Japan's Nippon Chemiphar 09 December 2009
- Cipla gets notice for overpricing drugs; denies liability 08 December 2009
- Celgene to acquire Gloucester Pharmaceuticals for $640 million 08 December 2009
- Templeton switches sides; backs Sun on Taro takeover 02 December 2009
- Genzyme starts shipments of drugs for two rare disorders 02 December 2009
- Jubilant and Eli Lilly extend collaboration for five years 01 December 2009
- Wockhardt settles with lender DBS Bank out of court 30 November 2009
- Sanofi-Aventis signs drug localisation pact with Russia 28 November 2009
- Ranbaxy launches generic herpes drug in US 27 November 2009
- Sun Pharma gets FDA nod for selling generic drug 27 November 2009
- General Atlantic may buy stake in Strides Arcolab 24 November 2009
- Merck wins summary judgment in Vioxx lawsuit in Texas 23 November 2009
- Merck receives FDA approval for new fertility drug for women 21 November 2009
- US FDA clears Boston Scientific's fully covered oesophageal stent 21 November 2009
- Bristol-Myers to divest Mead Johnson for $7.69 billion 16 November 2009
- Glenmark gets nod to market skin cream in US 16 November 2009
- Cipla launches generic drugs for swine flu treatment 14 November 2009
- Torrent opens exclusive human insulin unit for Novo Nordisk 14 November 2009
- Aurbindo to merge subsidiary Trident Life Sciences Ltd 13 November 2009
- Pfizer to slash R&D facilities post Wyeth merger 11 November 2009
- Sanofi-Aventis expands Regeneron research deal to $1 billion 11 November 2009
- India wins two creative Global Awards for healthcare communcations 11 November 2009
- Enzon to sell specialty pharma business 09 November 2009
- Dr Reddy's seeks US marketing rights for `Lipitor' generic 07 November 2009
- J&J to axe more than 7,000 jobs in restructuring 04 November 2009
- Wockhardt reports Rs54 crore Q3 net loss 31 October 2009
- Cadila launches first indigenously prepared TB drug 31 October 2009
- Ranbaxy posts Rs186.08 crore in Q2 profits 27 October 2009
- Astellas to terminate development of anti-human antibody for RA 26 October 2009
- EU watchdog places Biogen's Tysabri under scanner 24 October 2009
- Dr Reddy's July-September net zooms 106 per cent to Rs217 crore 23 October 2009
- Pfizer unit fined record $1.3 billion for drug misbranding 19 October 2009
- Pfizer completes Wyeth acquisition 16 October 2009
- Eli Lilly to hive off Tippecanoe laboratory to Evonik Industries 15 October 2009
- Piramal Lifesciences to invest Rs200 crore in drug researh 14 October 2009
- Merck KGaA acquires Banagalore bioscience firm 13 October 2009
- EU official raid Ranbaxy French unit 08 October 2009
- GSK receives orders for 440 million doses of H1N1 vaccine 06 October 2009
- Ranbaxy to market Daiichi Sankyo products in Mexico 05 October 2009
- Hunduja's Gulf Oil sells IDL Specialty Chemicals to Biocon 01 October 2009
- Boston Scientific and Johnson & Johnson settle patent disputes 30 September 2009
- Academia Sinica joins Eli Lilly's new TB drug discovery programme 30 September 2009
- Israeli drug firm Taro sues Sun Pharma in US 30 September 2009
- Wockhardt receives US FDA approval for prostrate drug 29 September 2009
- Merck & Co gets exclusive US rights for Afluria from CSL Biotherapies 29 September 2009
- Lupin buys US rights for cholesterol drug Antara 29 September 2009
- Abbott to acquire Belgian drug company Solvay for $6.6 billion 29 September 2009
- Pharma giants worried about India's generic expertise: Sharma 26 September 2009
- Strides Arcolab launches H1N1 drug 'Starflu' 26 September 2009
- US Army claims `modest' success with AIDS vaccine trials in Thailand 24 September 2009
- Wockhardt is top Indian pharma patentee; bags government award 24 September 2009
- Astellas files suit against Teva for patent infringement in the US 24 September 2009
- Venus Remedies outlicenses drug to South Korean firm 23 September 2009
- Bayer to supply WHO with drug for African sleeping sickness 23 September 2009
- Eli Lilly unveils plans to speed drug development 23 September 2009
- Pfizer, Wyeth to sell animal drugs business to Boehringer 23 September 2009
- Increasing incomes to boost costly drug sales: FICCI 22 September 2009
- Merck, Wellcome Trust tie up to make affordable drugs in India 19 September 2009
- Glaxo seeking stake in Dr Reddy's: report 18 September 2009
- Orchid receives USFDA approval for Zaleplon capsules 18 September 2009
- Natco Pharma launches H1N1 drug 'Natflu' 18 September 2009
- Ranbaxy in-licenses cosmetic product Neuronox from Medy-Tox, South Korea 17 September 2009
- Government opens window for retail sale of H1N1 drug 15 September 2009
- Eli Lilly plans 5,500 job cuts to save $1 billion 15 September 2009
- Suven Life Sciences secures 2 US patents for new chemicals 14 September 2009
- BASF India board okays Ciba India merger 14 September 2009
- Dr Reddy's scotches stake sale rumours 11 September 2009
- Six new national pharmaceutical institutes to be set up on PPP model 11 September 2009
- Biocon in hybrid drug development pact with Amylin 11 September 2009
- Hyderabad's Suven gets first payoff from Eli Lilly tie-up 08 September 2009
- Sigma acquires Bristol-Myers Sqibb's brands 07 September 2009
- Aurobindo Pharma receives USFDA, Swissmedic approval for drugs 07 September 2009
- States lose power to certify drug exports 07 September 2009
- Ranbaxy launches authorised generic version of Validus's Rocaltrol 03 September 2009
- GSK to test swine flu vaccine in India at selected sites 03 September 2009
- LEO Pharma to Acquire Peplin for $287.5 million 03 September 2009
- Dainippon Sumitomo close to buy US drug maker Sepracor 03 September 2009
- Pfizer agrees to pay $2.3 billion to settle illegal marketing case 03 September 2009
- Vivimed Labs completes buyback of FCCBs totalling $12.5 million 02 September 2009
- Roche buys Lonza's Singapore unit for $360 million 02 September 2009
- Facet Biotech, Trubion in $196 million cancer drug deal 31 August 2009
- Novartis moves Supreme Court on Glivec patent 29 August 2009
- SC refuses to hear Roche's patent plea against Cipla 28 August 2009
- Cipla to raise Rs1500 crore; eyes Chinese partner 27 August 2009
- Ranbaxy's peptic ulcer drug cleared for US launch 25 August 2009
- Delhi High Court allows Cipla to sell generic cancer drug 19 August 2009
- Glenmark, Forest drug trial for COPD fails 19 August 2009
- Glenmark faces GSK patent challenge in US over malaria drug 18 August 2009
- Aurobindo Pharma to acquire Trident Life Sciences 17 August 2009
- Swine flu bolsters Indian pharma stocks 11 August 2009
- Delhi HC rejects Reckitt Benkiser's claims against Wyeth 11 August 2009
- India to crack down on fake Chinese drugs 11 August 2009
- Merck, Schering-Plough shareholders approve $41-billion deal 10 August 2009
- Aurobindo wins FDA nod for generic drug 08 August 2009
- Dr Reddy's Lab launches skin patch pain reliever in India 06 August 2009
- FDA bans Teva Animal Health's veterinary drugs 03 August 2009
- Sun Pharma settles Ethyol dispute with MedImmune 03 August 2009
- Mylan says FDA approves its drug production 29 July 2009
- Merck's Q2 profit falls, but beats expectations 22 July 2009
- Daiichi's 'low' bid for Zenotech faces new hurdles 16 July 2009
- NPPA asks Cipla to pay for overcharging on drugs 10 July 2009
- Sun Pharma puts up brave face after FDA crackdown 27 June 2009
- Pfizer sweetens bid for India arm to Rs830 per share 25 June 2009
- GSK signs drug pact with Chroma Therapeutics 24 June 2009
- Clinical trials using humans must now be registered 18 June 2009
- Glaxo ties up with Dr Reddy's for emerging markets 15 June 2009
- China pushes fake "Indian" drugs in Africa 10 June 2009
- India gears up to mass-produce H1N1 flu vaccine 13 May 2009
- Wockhardt settles patent row with Orion Corporation 29 April 2009
- WHO worried over drug-resistant malaria strain 25 April 2009
- Cipla feels FDA heat: nine 'deviations' found 20 April 2009
- Natco, Dr Reddy's tie up for cancer generics 16 April 2009
- Pfizer seeks to increase stake in Indian arm 13 April 2009
- FDA nod for Stride Arcolabs' AIDS drug combo 11 April 2009
- Piramal Healthcare to shut down UK unit 02 April 2009
- Glenmark to withdraw painkiller from US market 02 April 2009
- Ranbaxy to launch Daiichi's hypertension drug in India 31 March 2009
- Novartis's open offer for Indian arm to begin on 14 May 27 March 2009
- Novartis makes open offer for 39 per cent in Indian arm 25 March 2009
- Bristol-Myers, Syngene open new R&D facility 24 March 2009
- UK, Australia okay drugs from Ranbaxy plant 24 March 2009
- Hikal plans to take over its own pharma co 23 March 2009
- Dr Reddy's pulling out of small global markets 21 March 2009
- Dr Reddy's sales in Russia and CIS top $150 million 19 March 2009
- Matrix gets tentative US FDA nod for HIV inhibitor drug 13 March 2009
- Takeda shares plummet as FDA delays new drug 09 March 2009
- Ranbaxy's cardio drug `Ramipril' gets US FDA approval 09 March 2009
- US drug firm Cephalon makes $329 million offer for Australia's Arana 27 February 2009
- Ranbaxy plant in India falsified data: US FDA 25 February 2009
- US, China in race for top slot in global wind industry 17 February 2009
- Dutch minister promises a re-look at drug seizures on patent issues 11 February 2009
- PPF ends opposition to Zentiva sale; Sanofi takeover likely 11 February 2009
- Indian medicines made safer from patent piracy 10 February 2009
- Medical world abuzz about cancer-killing CyberKnife 10 February 2009
- Danish drugmaker Lundbeck to acquire Ovation of US for $900 million 09 February 2009
- Piramal Healthcare denies reports of Glaxo, Sanofi bid 07 February 2009
- Government plans big push on generic drugs 06 February 2009
- Schering-Plough's quarterly results surpass expectations 04 February 2009
- Study suggests insulin may be treatment for Alzeheimer's 03 February 2009
- India, Brazil denounce seizure of medicines by Dutch authorities 31 January 2009
- WHO shelves redefinintion amidst protest from Indian drug makers 27 January 2009
- Glaxo buys UCB patents 24 January 2009
- FDA woes hit Ranbaxy in Q4 23 January 2009
- India plans to move WTO as EU confiscates drugs in transit 16 January 2009
- Exact Sciences rebuffs Sequenom's $41 million buyout offer 13 January 2009
- Centre acquires controlling stake in 2 drug firms 02 January 2009
- Pharma sales beat inflation 02 January 2009
- Amrutanjan to get makeover 26 December 2008
- FDA warns consumers about tainted weight-loss products 23 December 2008
- Infosys wins multi-million dollar AstraZeneca deal 15 December 2008
- Pharmaceutical companies asked to pass excise benefits to consumers 15 December 2008
- Pharma sector attracts Atlas Cycles and Shanku Group 06 December 2008
- Research proves branded drugs not superior to generics 05 December 2008
- Wockhardt gets US FDA approval for paediatrics drug 04 December 2008
- Ranbaxy in pact to market BioPro's brain tumour drug in India 03 December 2008
- J&J buys breast implant maker Mentor Corp for $1.07 billion 01 December 2008
- Plethico to take 20 per cent stake in CIS drug maker 29 November 2008
- Drug firms misusing patents to block cheaper generics: EU 28 November 2008
- Sun Pharma's US arm acquires Chattem 27 November 2008
- AstraZeneca, Abraxis rethink cancer drug deal 26 November 2008
- Sanofi settles Allegra, Nasacort patent suits with Teva, Barr 20 November 2008
- AstraZeneca agrees to cut drug prices in UK, stock plummets 20 November 2008
- Glenmark launches `Azathioprine' tablets in US 20 November 2008
- Teva in bid to make generic version of Gilead's AIDS drug Truvada 15 November 2008
- Wockhardt gets USFDA approval for insomnia drug sale 14 November 2008
- US FDA observations not to affect drug sales: Lupin 14 November 2008
- Daiichi Sankyo completes Ranbaxy acquisition 07 November 2008
- Sanofi's anti-obesity drug Acomplia pulled out of EU 25 October 2008
- Daiichi acquires 52.5 per cent in Ranbaxy 20 October 2008
- Cadila gets USFDA approval antyi-depressant Risperidone 20 October 2008
- Ranbaxy-Daiichi deal hits a regulatory bump 17 October 2008
- Wockhardt gets US FDA nod to market Ceftazidime injections 16 October 2008
- New anti-piracy law to be enacted in the US 15 October 2008
- Chennai's Malladi Drugs to set up global hub in Malaysia 08 October 2008
- Three scientists share Nobel prize for medicine 06 October 2008
- Jubilant in R&D, clinical trial joint venture with Eli Lilly 04 October 2008
- Ely Lilly, Deciphera tie up for cancer drug research 03 October 2008
- Tata's Advinus Therapeutics, J&J arm in drug development pact 01 October 2008
- Pharmaceutical offshoring to grow to Rs2,500 crore by 2012 29 September 2008
- Alpharma rejects King Pharmaceuticals' $1.55 billion offer as inadequate 27 September 2008
- Ranbaxy hires New York ex-mayor Giuliani to resolve issues with US FDA 18 September 2008
- US FDA bans import of over 30 Ranbaxy generic drugs 17 September 2008
- CSIR launches open source drug discovery 16 September 2008
- Emami doubles offer price to Rs15,000 per Zandu share 15 September 2008
- Essar Gujarat in petrochem technology licencing deal with CB&I 09 September 2008
- US FDA to list names of drugs under investigation 06 September 2008
- Cabinet likely to clear Daiichi-Ranbaxy deal next month 26 August 2008
- Lupin in marketing alliance with Forest for asthma product 19 August 2008
- Management expansion at McCann Healthcare Worldwide 19 August 2008
- Methadone a double-edged painkiller 18 August 2008
- Pfizer to settle Lipitor case with Canada's Apotex 11 August 2008
- UK Crown court rejects charges against Ranbaxy 23 July 2008
- Clinton initiates cheap malaria drugs programme 19 July 2008
- MNC rival trying to scuttle Daiichi deal: Ranbaxy 18 July 2008
- UK's Shire acquires maker of Firazyr, Jerini AG 04 July 2008
- Johnson & Johnson Nordic AB acquires Åmic 23 June 2008
- Daiichi to make open offer for Ranbaxy on August 8 16 June 2008
- Glenmark gets nod for marketing two drugs in US 30 May 2008
- Pharma firms threaten to stop production 28 May 2008
- Ranbaxy to develop new drugs for Merck & Co 10 May 2008
- Teams unravel heparin death mystery 02 May 2008
- US FDA turns down Merck's ER niacin / laropiprant 29 April 2008
- Government brings 1,421 drugs under Price Control Order 25 April 2008
- GlaxoSmithKline acquires Sirtris Pharmaceuticals 24 April 2008
- Teva to acquire Bentley Pharmaceuticals 01 April 2008
- Aurobindo acquires Italian generic pharma firm TAD 24 March 2008
- Japan's biggest drug maker to expand in the US 20 March 2008
- Ranbaxy to introduce dental drug Inersan in India, Nepal 18 March 2008
- Drugs to become cheaper: Ram Vilas Paswan 01 March 2008
- Dabur launches injection for cancer treatment in US 29 February 2008
- Baxter withdraws heparin blood thinners made from Chinese supplies 29 February 2008
- Matrix Labs may divest Docpharma 28 February 2008
- Shasun Chemicals technology licenses API technology to Merck 27 February 2008
- Sun Pharmaceutical buys Taro Pharma shares from Brandes 20 February 2008
- Zydus Cadila launches new drug for cancer therapy 15 February 2008
- Nicholas Piramal launches hypertension product 07 February 2008
- US FDA grants tentative approval to Teva's generic Flomax capsules 01 February 2008
- Sun Pharma launches generic version of Wyeth's Protonix 30 January 2008
- Shasun Chemicals to set up new facilities in N. America 28 January 2008
- US FDA approves Glenmark Pharmaceuticals Baddi semi-solids plant 28 January 2008
- Matrix Laboratories hikes stake in China's Mchem to 97 per cent 25 January 2008
- Nicholas Piramal buys Healthline's pharmaceuticals business 23 January 2008
- Suven Life Sciences receives second US patent 23 January 2008
- Wockhardt to demerge R&D business 18 January 2008
- US wants to open FDA office in India 11 January 2008
- Cephalon seeks second use for chemo drug 03 January 2008
- Suven Life Sciences receives first product patent in the US 27 December 2007
- Aurobindo Pharma gets US approval to sell generic Omnicef 19 December 2007
- Health minister to release Indian Pharmacopoeia 2007 17 December 2007
- Novartis plans to cut 22,00 jobs worldwide 13 December 2007
- Sun Pharma announces settlement of litigation over generic Exelon 06 December 2007
- Matrix Labs gets US FDA nod for HIV drug 05 December 2007
- French drug giant Sanofi-Aventis opens R&D centre in Goa 05 December 2007
- Nicholas Piramal in R&D collaboration with Merck & Co 19 November 2007
- Pfizer to acquire Coley Pharmaceutical for $164 million 19 November 2007
- US FDA approval Orchid's ANDA for Cefpodoxime Proxetil 17 November 2007
- Dr Reddy's gets US FDA nod for marketing Ciprofloxacin 17 November 2007
- Glenmark Pharma to spin off generics unit, list new unit next year 17 November 2007
- Merck agrees to settle Vioxx claims for $4.85 billion 15 November 2007
- GSK to launch cancer drug Tykerb in India 10 November 2007
- Biocon plans Rs 100 crore annual research spend 31 October 2007
- Glenmark signs up marketing deal with MyerZall Labs 27 October 2007
- Ranbaxy launches Osonase nasal spray in India 25 October 2007
- Himalaya Drug Company to expand retail presence 19 October 2007
- Ranbaxy follows Sun Pharma in demerging R&D business 19 October 2007
- USV in marketing tie-up with Germany''s Sebapharma 19 October 2007
- Government plans central authority for drug licensing 08 October 2007
- Avesthagen-Cipla JV acquires Siegfried Biologics in Germany 05 October 2007
- Toray develops Hepatitis C vaccine 28 August 2007
- Matrix to acquire residual holding in China''s Mchem group 25 August 2007
- Ipca-Ranbaxy alliance to market Metformin HCL tablets in US 14 August 2007
- Lupin to invest Rs200 crore in new plant, capacity addition 10 August 2007
- Patent tussle fallout: MNCs may turn cautious on India 07 August 2007
- Chennai court rejects Novartis patent challenge 06 August 2007
- KKR Boots' debt may devolve on underwriters 04 August 2007
- Biocon enters into JV with Neopharma of UAE 30 July 2007
- GlaxoSmithKline pharmaceuticals divests fine 26 July 2007
- China asks tainted food and drug firms to shut down 23 July 2007
- Roche buys Toyama''s arthritis drug for $370 million 26 June 2007
- US panel blocks Sanofi''s weight-loss drug 16 June 2007
- Dr Reddy's commences operations in Nigeria 16 June 2007
- Aurobindo Pharma rules out stake sale 13 June 2007
- Indian pharma to grow big in few years 24 May 2007
- NPPA strikes drug firms for raising MRP 24 May 2007
- Dr Reddy's is setting up two SEZs 19 May 2007
- US FDA approves Ranbaxy''s pravastatin sodium tablets 25 April 2007
- Bidding battle expected for Boots 10 April 2007
- Ranbaxy-GSK alliance to develop respiratory drug 02 April 2007
- Novartis slumps after pulling Zelnorm 31 March 2007
- Ranbaxy launches asthma drug 'Osovair' in India 30 March 2007
- Strides Arcolab gets tentative US FDA nod for AIDS drug 29 March 2007
- Is Torrent a serious contender for Merck? 23 March 2007
- Zydus Cadila acquires Liva Healthcare 17 March 2007
- Boots rejects KKR's £9.7 billion offer as being low 13 March 2007
- Merck suffers adverse Vioxx lawsuit in the US 13 March 2007
- Boots to consider KKR's £9.7 billion offer 12 March 2007
- Biocon to invest Rs 1,000 crore in Vizag SEZ 17 February 2007
- ADAG to rewrite drug distribution rules 10 February 2007
- Pfizer loses battle for Chinese name for Viagra 06 February 2007
- Dr Reddy's to join the race for Merck's generic business 05 February 2007
- Wyeth sued over Zosyn patent 03 February 2007
- Global collaboration to develop new anti-obesity compounds 02 February 2007
- Pfizer wins Norvasc patent case against Synthon 02 February 2007
- Ranbaxy launches two NDDS Urology products in India 30 January 2007
- US move to prevent restrictions on generic drugs 18 January 2007
- Biocon grants marketing license for cancer drug in Pakistan 18 January 2007
- Mylan completes stake acquisition in Matrix 10 January 2007
- Suven Life Sciences Secures Patent 09 January 2007
- Only 12 per cent of drugs market to be under price control 08 January 2007
- Biocon in joint venture with Abu Dhabi-based Neopharma 06 January 2007
- Chemists body in TN plans distribution firm 05 January 2007
- Dabur launches new delivery system for anti-cancer drug 04 January 2007
- Lupin awarded tentative US FDA approval for sertraline 02 January 2007
- Aurobindo Pharma acquires Dutch company 30 December 2006
- Ipca's 'Atenolol' bulk drug registered in China 29 December 2006
- Aurobindo receives approval for AIDS drug 22 December 2006
- Iceland''s Actavis acquires manufacturing plant in Chennai 22 December 2006
- Why is RLS interested in GeneMedix? 22 December 2006
- Ranbaxy wins Lipitor patent against Pfizer in Australia 21 December 2006
- Glaxo buys Genmab's leukemia drug for record $2.1 billion 19 December 2006
- Ranbaxy gets USFDA approval for Cefprozil anti-infective tablets 15 December 2006
- Forest''s Lexapro tops anti-depresant drug trial 08 December 2006
- Akorn-Strides JV takes product pipeline to 29 ANDAs 07 December 2006
- Dabur Pharma gets US FDA approval for cancer drug 07 December 2006
- Panacea signs joint venture pact with Cambridge Biostability of UK 06 December 2006
- Dr Reddy's to raise Rs 1,027 crore through additional ADS issue 30 November 2006
- FDA orders withdrawal of Wockhardt's insulin brand 'Wosulin' 25 November 2006
- Nicholas Piramal signs collaboration pact with BioSyntech 17 November 2006
- Tata Group''s Advinus to develop metabolic drugs for Merck 16 November 2006
- US Court''s Zocor verdict to benefit Ranbaxy and Dr Reddy''s 15 November 2006
- Zydus Cadila files novel drug candidate for obesity disorders 14 November 2006
- Merieux Alliance acquires majority stake in Shantha Biotechnics 09 November 2006
- Panacea Biotec's R&D centre gets government recognition 07 November 2006
- Government reduces dealer margins on 886 medicines 31 October 2006
- Ranbaxy to introduce Debiopharm's gastro drug in India 23 October 2006
- New Drugs Act: What''s in store for Indian drug industry? 19 October 2006
- Claris Life Sciences to expand capacity and product portfolio 13 October 2006
- Granules India forms joint venture with Chinese company 12 October 2006
- US FDA approves Aurobindo Pharma''s Meloxicam for US sales 06 October 2006
- Nicholas Piramal acquires Boots Piramal Healthcare 03 October 2006
- Dr Reddy's opens manufacturing facility at Visakhapatnam 26 September 2006
- Sterling Bio to acquire gelatin company in China 26 September 2006
- Ipca Laboratories in marketing alliance with Ranbaxy for US sales 21 September 2006
- Orchid's formulation and API facilities approved by UK MHRA 21 September 2006
- US FDA approves Ranbaxy's sale of furosemide in the US 21 September 2006
- German Remedies launches third-generation inhaler for asthamatics 20 September 2006
- Biocon launches cancer anti-body drug BioMab-EGFR 18 September 2006
- Fifth volume of Ayurveda Pharmacopoeia released 18 September 2006
- Dr Reddy's acquires Spain's Litaphar: CNBC 18 September 2006
- Ranbaxy to market Ethypharm's cardiovascular drug in India 18 September 2006
- Wockhardt to develop SEZ near Aurangabad for its global biopharma hub 18 September 2006
- Is pharma retailing the next big opportunity? 13 September 2006
- Government to grant limited period protection for new drugs 05 September 2006
- Wockhardt's Cefotaxime injection receives US FDA approval 31 August 2006
- India to host Asia biotech meet 30 August 2006
- Ranbaxy wins two additional atorvastatin patents in Norway 30 August 2006
- TAKE Solutions wins Dabur Pharma order 24 August 2006
- Unbranded drugs may get cheaper by 50-60 per cent 18 August 2006
- US FDA approves drug to treat rare genetic disease 25 July 2006
- Lupin gets US FDA approval for Meloxicam 20 July 2006
- New Genentech eye drug gets FDA approval 01 July 2006
- Ranbaxy's 'Cefprozil' gets US FDA approval 01 July 2006
- GE ties up with Manipal Hospital for clinical trials 29 June 2006
- Wockhardt UK expanding Byetta manufacturing capacity 16 June 2006
- Nicholas Piramal to acquire Pfizer''s UK Facility 15 June 2006
- Merck & Co develops new diabetes drug 14 June 2006
- Lupin gets US FDA approval for Cefdinir 24 May 2006
- US FDA approves Wockhardt's Waluj plant 11 May 2006
- Roche reports strong global sales for Tamiflu 27 April 2006
- Biocon Biopharmaceuticals' new biologics facility 17 April 2006
- Merck wins second Vioxx lawsuit 18 February 2006
- Ranbaxy raises $400 million from FCCB issue 16 February 2006
- Dr Reddy's, Ranbaxy lead race to acquire 3i's stake in Betapharm 03 February 2006
- Dr Reddy's Laboratories enters into agreement with Merck 01 February 2006
- Natco Pharma acquires 75 per cent in US retail store 31 January 2006
- Boston Scientific beats J&J to acquire Guidant for $27 billion 25 January 2006
- Aurobindo receives UK MHRA approval 20 January 2006
- Ranbaxy in co-marketing agreement with Ferring of Switzerland 10 January 2006
- Dishman Pharmaceuticals clarifies news item 06 January 2006
- Roche grants Tamiflu licence to Hyderabad firm Hetero Drugs 24 December 2005
- Merck, ICMR to conduct joint trials on cervical cancer vaccine 22 December 2005
- Ranbaxy, Cephalon to settle Provigil patent litigation 22 December 2005
- JB Chemicals to set-up wholly owned subsidiary in Russia 21 December 2005
- Dishman Pharmaceuticals acquires IO3S, Switzerland 20 December 2005
- Natco Pharma finalises terms for supply of two onco formulations 20 December 2005
- US FDA approves Lupin's cefprozil suspension, Orchid's tablets 20 December 2005
- Aurobindo Pharma selected for IDMA''s patents appreciation award. 15 December 2005
- Aurobindo Pharma''s anti-AIDS drug selected by WHO 12 December 2005
- Natco Pharma receives Patent Appreciation Award 12 December 2005
- Transgene Biotek develops oral vaccines for diabetes and Hepatitis B 07 December 2005
- Ranbaxy offers to help U S combat avian flu 02 December 2005
- New Indo-UK JV company to recruit patients for drug trials 01 December 2005
- Lupin receives US FDA approval for Cephalexin capsules 01 December 2005
- Tentative US FDA approval for Zydus Cadila's gatifloxacin tablets 29 November 2005
- Ranbaxy honours scientists for outstanding research 28 November 2005
- Lupin receives IND approval from DCGI for Desoris LLL-3348 28 November 2005
- US Court of Appeals upholds preliminary injunction against Ranbaxy 23 November 2005
- AstraZeneca sues Ranbaxy on Nexium patent 22 November 2005
- Zydus Cadila receives approval for Sertraline from AFSSAPS, France 22 November 2005
- Dr Reddy''s to acquire Roche business in Mexico 08 November 2005
- Orchid Chemicals' fire victims were insured: K Raghavendra Rao 08 November 2005
- Venkat Pharma secures $400,000-US order for dietary supplements 02 November 2005
- Glenmark Pharmaceuticals targets GPs 10 October 2005
- Orchid, AstraZenwca, receive Frost and Sullivan pharma awards 03 October 2005
- Aurobindo receives approval for sertraline hydrochloride tablets 27 September 2005
- Matrix acquires 43 per cent stake in Swiss firm Explora Labs 21 September 2005
- Pharma sector to top Rs.60,000 crore by ''08 21 September 2005
- NPPA revises 16 bulk drug prices 20 September 2005
- Government evaluating ''data exclusivity'' demand of pharma companies 17 September 2005
- Eisai becomes first Japanese pharma firm to enter India 17 September 2005
- Ranbaxy obtains US FDA approval for high BP drug 14 September 2005
- Shanta Biotechnics launches 4-in-1 combination vaccine 20 August 2005
- Eli Lilly launches anti-diabetes drug variant 11 August 2005
- Sun Pharma to buy manufacturing site in Hungary 11 August 2005
- Maharashtra FDA questions claims of nutraceuticals 28 June 2005
- Nectar Lifesciences to come out with Rs100cr IPO 07 June 2005
- Kopran to shift focus to global markets 06 June 2005
- USFDA gives tentative nod for Ranbaxy drug 01 June 2005
- HCL Tech and IIT Delhi to work on new drugs 04 May 2005
- Johnson & Johnson launches the stent war 29 March 2005
- Glenmark acquires another brand in Brazil 18 March 2005
- Patent Bill to be introduced next week 17 March 2005
- Orchid in deal with Stada for generic drug products 17 March 2005
- Mexican mission woos Indian drug majors 16 March 2005
- GSK India announces buyback 15 March 2005
- Zydus ties up Mallinckrodt to market generics in USA 10 March 2005
- GlaxoSmithKline to locate first Indian vaccine plant at Nashik 23 February 2005
- GlaxoSmithKline Q4-05 up at 61.4% 17 February 2005
- Dr Reddy''s cardio drug candidate undergoing clinical trials 09 February 2005
- Zydus Cadila files its first IND application for new molecule 09 February 2005
- InnoCentive signs MoU with IICT, Hyderabad 04 February 2005
- Pharma, IT to benefit from patents: Evalueserve 04 February 2005
- Zydus Cadila receives US FDA approvals for Clindamycin 01 February 2005
- Ranbaxy makes three fresh ARV filings to WHO 25 January 2005
- Shantha Bio launches DNA Erythropoietin 24 January 2005
- Ranbaxy Top brass reshuffled 22 January 2005
- Dr Mahendra Patel joins Zydus Pharmaceuticals 20 January 2005
- Ranbaxy Q4 results disappoints 19 January 2005
- Shantha Biotech Introduces Shanvac-B in BD UnijectT 10 January 2005
- New Year rings in new patents regime for pharma cos 01 January 2005
- Nicholas Piramal to take over UK''s Rhodia 18 December 2004
- Zydus and Mayne (Australia) sign MoU for JV in India 13 December 2004
- Bonanza ahead for generic drug majors 09 December 2004
- Sun Pharma to issue $75 million FCCB 06 December 2004
- Pankaj Patel declared 'best pharma man of the year' by FIIE 01 December 2004
- Sun Pharma launches $225 million FCCB 19 November 2004
- Paswan caps drug prices 18 November 2004
- Ranbaxy withdraws its antiretroviral''s from WHO list 10 November 2004
- Stronger performance from Shasun Chemicals and Drugs Limited 18 October 2004
- CII pharma summit for ''India pharma Inc'' 13 October 2004
- Hanmer & Partners acquires Doc Asia 27 August 2004
- Dishman Pharma setting up new R&D facility 11 August 2004
- Sun Pharmaceuticals proposes share swap with Phlox Pharma 03 August 2004
- Ranbaxy net down six per cent 02 August 2004
- Charak Pharma in joint venture with IL&FS Investmart 23 July 2004
- India emerges as global hub for pharma outsourcing 12 July 2004
- Jagsonpal spreads its wings 10 July 2004
- Natco Pharma unveils new drug 26 June 2004
- Jagsonpal amongst India's top fifty pharma companies 16 June 2004
- FIIs pull out of Dr Reddy''s Laboratories 31 May 2004
- Krebs to diversify 31 May 2004
- Sun Pharma plants get US regulatory clearance 28 May 2004
- Two Sun Pharma units gets USFDA approval 27 May 2004
- Granules India gets USFDA nod 24 May 2004
- Orchid's US discovery JV successful 22 May 2004
- Dr Reddy''s acquires US company Trigenesis 07 May 2004
- Wockhardt acquires German firm Esparma 07 May 2004
- Sanofi India's fortune looking up 05 May 2004
- Jagsonpal Pharma net rises 227 per cent 03 May 2004
- Ranbaxy in pact for new drug discovery 30 April 2004
- Novartis launches development centre in Mumbai 28 April 2004
- Global pharma eyes India as BPO hub 26 April 2004
- Maxfair Drugs launches ayurvedic formulations in Kerala 24 April 2004
- Orchid Pharma soon to file ANDA from its new plant 13 April 2004
- Orchid Pharma soon to file ANDA from its new plant 02 April 2004
- Shreya launches new generation ''Viagra'' variant 01 April 2004
- Dishman IPO price band finalised 25 March 2004
- Nicholas Piramal expands its Clinical Research facility 24 March 2004
- Zydus Cadila launches Nucoxia 17 March 2004
- Sun Pharma increases holding in Caraco 16 March 2004
- Matrix Labs gets US approval for second unit 13 March 2004
- Ranbaxy crosses the billion dollar mark 11 March 2004
- Morepen gets USFDA approval for API manufacturing 09 March 2004
- US reinsurers wary of Indian pharma firms 09 March 2004
- Product patents a major issue at Bio Asia 01 March 2004
- Pfizer recalls liquid Gelusil 28 February 2004
- One more CoS for Orchid Chemicals 19 February 2004
- Pharmexcil to be headquartered in Hyderabad 10 February 2004
- Sun Pharma to increase holdings in Caraco to 60 per cent 09 February 2004
- Nicholas Piramal merges Canere Actives and Fine Chemicals Pvt. Ltd. 07 February 2004
- Nicholas Piramal Q3 growth up 76.1 per cent 07 February 2004
- Sun Pharma logs healthy growth 03 February 2004
- Ranbaxy enters the field of herbal medicine 22 January 2004
- Orchid posts good Q3 performance 16 January 2004
- USFDA approval for Ranbaxy drug 10 January 2004
- Nicholas Piramal, SPPL debt programmes reaffirmed A1+ 06 January 2004
- Vera Laboratories to come out with a preferential issue 02 January 2004
- Orchid Aurangabad facility bags ISO 14001, OHSAS 18001 31 December 2003
- Divi''s, Matrix scrip prices cross leading pharma firms'' prices 29 December 2003
- Nicholas Piramal buys partner''s 50% stake in Sarabhai Piramal 26 December 2003
- Indian pharmaceutical majors oppose EMR granted to Novartis 23 December 2003
- European approval for Orchid Chemical's drug 18 December 2003
- USFDA approval for Orchid 05 December 2003
- WHO declares pre-qualification of Ranbaxy''s Triviro-LNS tablets 04 December 2003
- Bexel to conduct human trials 03 December 2003
- Nicholas Piramal enters into alliance with Biogen Idec, USA 02 December 2003
- Torrent to increase presence, set up export base in Germany 22 November 2003
- Novo Nordisk unveils 2 insulin 10 November 2003
- Orchid income at Rs 162 crore 04 November 2003
- Zydus Cadila Q2 net rises 30% 20 October 2003
- Orchid Pharma's API facilities inspected by EDQM, MHRA UK 06 October 2003
- Caraco Pharma gets USFDA nod for tizanidine hydrochloride 03 October 2003
- Kopran may rope in strategic financial partner for recast plan 24 September 2003
- Unichem Laboratories to set up formulations facility in Himachal 24 September 2003
- Ranbaxy to invest Rs 120 crore for R&D in Andhra Pradesh 22 September 2003
- Meet brings to fore opportunities in European pharma industry 22 September 2003
- Orchid JV manufacturing facility in China commissioned 20 September 2003
- Mumbai to host Global Pharma Business Convention soon 23 August 2003
- Hikal''s main focus : Pharma 09 August 2003
- In the pink of health 21 July 2003
- Hikal declares bonus share of 1 : 2 14 July 2003
- Wockhardt buys CP Pharma 10 July 2003
- Zydus Cadila's net profit zooms by 27% 03 May 2003
- Kee Pharma offers Melagenina Plus for vitiligo patients 24 April 2003
- Access to medicines 17 April 2003
- Shasun launches Shacryl-30 D; gets US company’s licence 03 March 2003
- India asked to lead battle against developed world on patent issue 26 February 2003
- Orchid Pharma's Cephalexin approved by USFDA, EDQM 24 February 2003
- Glenmark Pharmaceuticals to divest subsidiary for Rs 35 crore 10 February 2003
- Orchid Chemicals net down to Rs 9.51 cr; turnover at 346.45 cr 28 January 2003
- Chemtech + Pharma World Expo to start in Mumbai on 22 Jan 18 January 2003
- DCGI asks ICMR to chart guidelines for stem-cell research 13 January 2003
- Zydus Cadila, Berna Biotech tie up to develop cancer vaccines 13 January 2003
- IDBI may bid again for strategic sell-off of Hind Antibiotics 11 January 2003
- GlaxoSmithKline declares second interim dividend of 37% 21 December 2002
- Sun Pharmaceuticals approves resolutions for split, buyback 21 December 2002
- Caraco, Sun Pharma sign R&D pact for 25 new generic drugs 09 December 2002
- Multinational, domestic pharma firms lock horns over R&D data 09 December 2002
- Ranbaxy to provide AIDS drugs to 10 lakh patients 29 November 2002
- Gland Pharma sets up R&D centre near Hyderabad 28 November 2002
- Alembic gets nod to market third-generation cephalosporin drug 27 November 2002
- Alembic to diversify into speicalty chemicals, biotechnology 18 November 2002
- Orchid Chemicals procures USFDA approval for Cephalexin 11 November 2002
- Kopran promoters, FIs, banks offload 18% stake in company 08 November 2002
- Novartis acquires global rights for Torrent’s AGE compound 07 November 2002
- Hikal clocks 28% sales growth at Rs 32 crore in second quarter 31 October 2002
- Cheryl’s Cosmetics to expand operations, to train professionals 29 October 2002
- Sun Pharma clocks 12% turnover, 14% PAT increase in Q2 29 October 2002
- Ranbaxy Laboratories clocks Rs 1,594-million Q2 net profit 18 October 2002
- Dr Reddy’s Labs to appeal US court ruling on infringement 14 October 2002
- Morepen Laboratories net profit up to Rs 168 million in Q2 14 October 2002
- Boots Piramal to enter vitamins, minerals, food supplements 10 October 2002
- India emerges hot market for human drug development testing 08 October 2002
- Government likely to amend D&C Act to curb illicit drug trade 07 October 2002
- SSI plans to launch BCG, rabies vaccines soon 04 October 2002
- Ranbaxy secures 10% stake in Nihon Pharma 26 September 2002
- Ranbaxy gets USFDA approval for Terazosin 26 September 2002
- RPG Life unveils nephrocare pharma division 24 September 2002
- Bayer recasts activities, gets into OTC sector 20 September 2002
- DCI team clears Sun Pharma research facility 18 September 2002
- Matrix to merge Vorin, Medicorp with itself 16 September 2002
- Novartis sale of property to Kingston through 09 September 2002
- Max India to exit pharmaceutical business 05 September 2002
- Hikal, Rockwell in enterprise integration JV 02 September 2002
- Dr Reddy’s grants employee stock options 27 August 2002
- Ranbaxy refutes Glaxo’s charge of stealing 24 August 2002
- Himalaya unveils women’s healthcare drugs 23 August 2002
- Alembic to launch new drug delivery system 05 August 2002
- Ranbaxy acquires Signature Pharma facility 23 July 2002
- Orchid Chemicals in equal JV with NCPC 20 July 2002
- Magan Industries forays into biotech, pharma 17 July 2002
- IAVI to begin human trials on HIV vaccine 22 May 2002
- Maharashtra FDA plans to apply GMP rules 22 May 2002
- Unichem gets MCA nod for HP plant 18 March 2002
- Astra open offer for Indian subsidiary 09 March 2002
- In placebo limbo? 08 February 2002
- Maharashtra hikes drug license fee 08 February 2002
- Pharma sector fared well in 2001 28 December 2001
- Kerala to preserve, promote ayurveda 24 December 2001
- Zydus website on healthy lifestyle 15 December 2001
- Sildenafil citrate drug sales surge 05 December 2001
- in China 28 November 2001
- Dr Reddys to challenge patents on drugs 26 November 2001
- Iodex goes to SmithKline Healthcare 26 November 2001
- Andhra Pradesh to set up Pharma City 23 November 2001
- Alembic to rejig business operations 15 November 2001
- Wockhardt files investigational application 15 November 2001
- Rediscovering Indian pharma market 10 November 2001
- Advanced anthrax vaccine developed 06 November 2001
- Cadila Pharma gets US, UK patents 06 November 2001
- Dr Reddys Labs launches Hyalosyn 06 November 2001
- Sun Pharma to bifurcate subsidiary 03 November 2001
- Zydus Alidac launches Bonmax 03 November 2001
- Cipla comes under Sebi investigation 25 October 2001
- Imunus launches 2 new Aids molecules 24 October 2001
- Lupin to make HIV cocktail drugs 24 October 2001
- Ranbaxy gets nod for Lisinopril 24 October 2001
- Unichem in pact with IIS 24 October 2001
- Aventis expects Arava to do well 12 October 2001
- Caraco makes, markets two drugs in US 04 October 2001
- Ajanta to offload stake in Kazakh firm 26 September 2001
- Ajanta, Kopran drop plan to buy brands 20 September 2001
- Zydus Cadila, Kopran join hands 18 September 2001
- Chinese pharma units to face anti-dumping duty 17 September 2001
- Oushadi to make veterinary medicines 14 September 2001
- Chemists prepare for face-off with manufacturers 16 March 2001
- Drug major changes policy for AIDS drug 16 March 2001
- Glaxo SmithKline reaches agreement with US FTC 18 December 2000
- Eli Lilly arthritis drug deal a forerunner for acquisition ? 17 November 2000
- Nycomed-Amersham to move research to China 14 November 2000
- Popular medicines pulled out of shelves by regulators 14 November 2000
- Pharma companies combine forces to battle spurious drugs 30 October 2000
- List of bulk drugs under Drug Price Control Order 08 March 2000
- NPPA slashes prices of two bulk drugs 08 March 2000
- US FDA to formulate new guidelines for botanicals 11 February 2000
- Merger impact in India 07 February 2000
- Global sales up nine per cent 19 January 2000
- About Novopharm 13 January 2000
- Ranbaxy to sell ranitidine 75mg tablets in the US 13 January 2000
- Rationalising drug distribution in India 07 January 2000
- The Medicine Shoppe 07 January 2000
- Foreign investment limit raised to 74% 06 January 2000
- Ajanta Pharma's drug for macular degeneration 03 January 2000
- Abbreviated New Drug Application (ANDA) 01 January 2000
- Distribution margins in India 01 January 2000
- Drug distribution channels 01 January 2000
- RDCA to form retail co-operative society in Mumbai 01 January 2000
- Subiksha 01 January 2000
- NPPA revises prices of 26 formulations 28 December 1999
- Table of revised/fixed prices 28 December 1999
- Marketing alliances can hurt 25 November 1999
- Ban on vitamins only on high-dose formulations 16 November 1999
- Pharmaceutical exports up 3 per cent 16 November 1999
- Nicholas Piramal will gain from vitamin A price hike 10 November 1999
- Vitamin A manufacturing process 10 November 1999
- Vitamin A - unattractive business? 06 November 1999
- Unichem eyeing analgesic brands 22 September 1999
- Unichem launches women's healthcare division 22 September 1999
- Alpha drugs referred to BIFR 14 September 1999
- Alpha drugs referred to BIFR 10 September 1999
- Two views on controls 10 September 1999
- Ranbaxy to raise research spending to 6 per cent of sales by 2002 09 September 1999
- J&J hives off adhesives unit to Premchand group 12 August 1999
- Dabur launches anti-hepatitis product 23 June 1999
- Formulations grew 14% in 1998: IMS 21 June 1999
- Glaxo, Ranbaxy, Cipla top rankings in 1998: IMS 21 June 1999
- Glaxo, Ranbaxy, Cipla top rankings in 1998: IMS 21 June 1999
- Ranbaxy pushes Pravosin to phase-1 trials 30 May 1999
- Hoechst puts four brands on the block 29 May 1999
- Glaxo acquires five veterinary brands from ICI 20 May 1999
- Wockhardt preparing for competition 27 April 1999
- Aurobindo turns cold on Dee Pharma unit 24 April 1999
- NPPA losses charm as govt clips price fixing powers 24 April 1999
- Cipla eyes US generics market, in talks for alliance 22 April 1999
- Parke-Davis to extend Benadryl brand name 22 April 1999
- Zidovudine will boost Glaxo 22 April 1999
- Abbott Labs diversifying 01 September 1998
- Abbott's new businesses, low-cost oppurtunism 01 September 1998
